ONTOLOGY REPORT - ANNOTATIONS
|
|||||||||||||||||||||||||||||||
2,3,7,8-tetrachlorodibenzodioxine
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | Abca6 | ATP-binding cassette, subfamily A (ABC1), member 6 |
|
multiple interactions | ISO | 10 | 99,626,334 | 99,693,870 | RGD:6480464 | CTD | |
| G | Abca8a | ATP-binding cassette, subfamily A (ABC1), member 8a |
|
increases expression | ISO | 10 | 99,477,700 | 99,544,364 | RGD:6480464 | CTD | |
| G | Abhd11 | abhydrolase domain containing 11 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Abi3bp | ABI family, member 3 (NESH) binding protein |
|
decreases expression | ISO | 11 | 44,853,302 | 45,072,354 | RGD:6480464 | CTD | |
| G | Abracl | ABRA C-terminal like |
|
increases expression | ISO | 1 | 13,063,558 | 13,073,748 | RGD:6480464 | CTD | |
| G | Acyp2 | acylphosphatase 2, muscle type |
|
multiple interactions | ISO | 14 | 111,507,725 | 111,512,680 | RGD:6480464 | CTD | |
| G | Acyp2 | acylphosphatase 2, muscle type |
|
multiple interactions | ISO | 14 | 111,507,725 | 111,512,680 | RGD:6480464 | CTD | |
| G | Adamts9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
|
increases expression | ISO | 4 | 126,996,604 | 127,198,909 | RGD:6480464 | CTD | |
| G | Adamts9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
|
decreases expression | ISO | 4 | 126,996,604 | 127,198,909 | RGD:6480464 | CTD | |
| G | Adat2 | adenosine deaminase, tRNA-specific 2 |
|
decreases expression | ISO | 1 | 8,358,164 | 8,372,650 | RGD:6480464 | CTD | |
| G | Adat2 | adenosine deaminase, tRNA-specific 2 |
|
multiple interactions | ISO | 1 | 8,358,164 | 8,372,650 | RGD:6480464 | CTD | |
| G | Agfg1 | ArfGAP with FG repeats 1 |
|
multiple interactions | ISO | 9 | 82,162,480 | 82,216,301 | RGD:6480464 | CTD | |
| G | Ago4 | argonaute RISC catalytic component 4 |
|
affects expression | ISO | 5 | 145,857,594 | 145,902,950 | RGD:6480464 | CTD | |
| G | Aim1 | absent in melanoma 1 |
|
decreases expression | ISO | 20 | 47,861,952 | 47,926,975 | RGD:6480464 | CTD | |
| G | Aim1 | absent in melanoma 1 |
|
decreases expression | ISO | 20 | 47,861,952 | 47,926,975 | RGD:6480464 | CTD | |
| G | Alg12 | asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase |
|
decreases expression | ISO | 7 | 127,109,296 | 127,123,482 | RGD:6480464 | CTD | |
| G | Alk | anaplastic lymphoma receptor tyrosine kinase |
|
decreases expression | ISO | 6 | 23,009,061 | 23,730,939 | RGD:6480464 | CTD | |
| G | Angptl7 | angiopoietin-like 7 |
|
decreases expression | ISO | 5 | 165,579,768 | 165,583,680 | RGD:6480464 | CTD | |
| G | Ankhd1 | ankyrin repeat and KH domain containing 1 | decreases expression | ISO | RGD:6480464 | CTD | |||||
| G | Ankhd1-Eif4ebp3 | Ankhd1-Eif4ebp3 fusion transcript |
|
decreases expression | ISO | 18 | 29,201,304 | 29,304,954 | RGD:6480464 | CTD | |
| G | Antxr2 | anthrax toxin receptor 2 |
|
multiple interactions | ISO | 14 | 12,875,632 | 13,107,975 | RGD:6480464 | CTD | |
| G | Antxr2 | anthrax toxin receptor 2 |
|
multiple interactions | ISO | 14 | 12,875,632 | 13,107,975 | RGD:6480464 | CTD | |
| G | Antxr2 | anthrax toxin receptor 2 |
|
multiple interactions | ISO | 14 | 12,875,632 | 13,107,975 | RGD:6480464 | CTD | |
| G | Antxr2 | anthrax toxin receptor 2 |
|
increases expression | ISO | 14 | 12,875,632 | 13,107,975 | RGD:6480464 | CTD | |
| G | Ap1g2 | adaptor-related protein complex 1, gamma 2 subunit |
|
increases expression | ISO | 15 | 33,205,056 | 33,212,801 | RGD:6480464 | CTD | |
| G | Ap1m2 | adaptor-related protein complex 1, mu 2 subunit |
|
multiple interactions | ISO | 8 | 20,385,982 | 20,396,146 | RGD:6480464 | CTD | |
| G | Ap3s2 | adaptor-related protein complex 3, sigma 2 subunit |
|
multiple interactions | ISO | 1 | 135,653,104 | 135,689,454 | RGD:6480464 | CTD | |
| G | Apex2 | APEX nuclease (apurinic/apyrimidinic endonuclease) 2 |
|
multiple interactions | ISO | X | 39,811,484 | 39,832,225 | RGD:6480464 | CTD | |
| G | Apex2 | APEX nuclease (apurinic/apyrimidinic endonuclease) 2 |
|
increases expression | ISO | X | 39,811,484 | 39,832,225 | RGD:6480464 | CTD | |
| G | Arhgap44 | Rho GTPase activating protein 44 |
|
decreases expression | ISO | 10 | 51,313,035 | 51,479,556 | RGD:6480464 | CTD | |
| G | Arhgap6 | Rho GTPase activating protein 6 |
|
decreases expression | ISO | X | 45,638,826 | 46,180,012 | RGD:6480464 | CTD | |
| G | Arhgap6 | Rho GTPase activating protein 6 |
|
increases expression | ISO | X | 45,638,826 | 46,180,012 | RGD:6480464 | CTD | |
| G | Armc9 | armadillo repeat containing 9 |
|
increases expression | ISO | 9 | 84,949,896 | 85,040,301 | RGD:6480464 | CTD | |
| G | Arvcf | armadillo repeat gene deleted in velo-cardio-facial syndrome |
|
multiple interactions | ISO | 11 | 84,582,208 | 84,639,874 | RGD:6480464 | CTD | |
| G | Arvcf | armadillo repeat gene deleted in velo-cardio-facial syndrome |
|
multiple interactions | ISO | 11 | 84,582,208 | 84,639,874 | RGD:6480464 | CTD | |
| G | Arvcf | armadillo repeat gene deleted in velo-cardio-facial syndrome |
|
decreases expression | ISO | 11 | 84,582,208 | 84,639,874 | RGD:6480464 | CTD | |
| G | Arxes2 | adipocyte-related X-chromosome expressed sequence 2 |
|
increases expression | ISO | X | 123,288,542 | 123,289,390 | RGD:6480464 | CTD | |
| G | Asb17 | ankyrin repeat and SOCS box-containing 17 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Atp5o | ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
|
multiple interactions | ISO | 11 | 31,914,320 | 31,920,632 | RGD:6480464 | CTD | |
| G | Atp5o | ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
|
increases expression | ISO | 11 | 31,914,320 | 31,920,632 | RGD:6480464 | CTD | |
| G | Atp8a1 | ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
|
multiple interactions | ISO | 14 | 42,923,309 | 43,165,666 | RGD:6480464 | CTD | |
| G | Atp8a1 | ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
|
decreases expression | ISO | 14 | 42,923,309 | 43,165,666 | RGD:6480464 | CTD | |
| G | Atp8a1 | ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
|
increases expression | ISO | 14 | 42,923,309 | 43,165,666 | RGD:6480464 | CTD | |
| G | Atp8a1 | ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
|
increases expression | ISO | 14 | 42,923,309 | 43,165,666 | RGD:6480464 | CTD | |
| G | Axl | Axl receptor tyrosine kinase |
|
increases expression | ISO | 1 | 80,964,751 | 80,994,300 | RGD:6480464 | CTD | |
| G | Azgp1 | alpha-2-glycoprotein 1, zinc-binding |
|
increases expression | ISO | 12 | 17,492,913 | 17,498,949 | RGD:6480464 | CTD | |
| G | Azgp1 | alpha-2-glycoprotein 1, zinc-binding |
|
multiple interactions | ISO | 12 | 17,492,913 | 17,498,949 | RGD:6480464 | CTD | |
| G | Azgp1 | alpha-2-glycoprotein 1, zinc-binding |
|
decreases expression | EXP | 12 | 17,492,913 | 17,498,949 | RGD:6480464 | CTD | |
| G | Azi2 | 5-azacytidine induced 2 |
|
multiple interactions | ISO | 8 | 122,961,302 | 122,985,601 | RGD:6480464 | CTD | |
| G | B2m | beta-2 microglobulin |
|
increases expression | ISO | 3 | 108,927,919 | 108,932,718 | RGD:6480464 | CTD | |
| G | B2m | beta-2 microglobulin |
|
decreases expression | ISO | 3 | 108,927,919 | 108,932,718 | RGD:6480464 | CTD | |
| G | B2m | beta-2 microglobulin |
|
decreases expression | EXP | 3 | 108,927,919 | 108,932,718 | RGD:6480464 | CTD | |
| G | B3galnt2 | beta-1,3-N-acetylgalactosaminyltransferase 2 |
|
increases expression | ISO | 17 | 59,531,872 | 59,576,151 | RGD:6480464 | CTD | |
| G | B3galt2 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
|
increases expression | ISO | 13 | 57,474,131 | 57,483,142 | RGD:6480464 | CTD | |
| G | B3gnt1 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 |
|
multiple interactions | ISO | 1 | 207,659,039 | 207,661,261 | RGD:6480464 | CTD | |
| G | B3gnt5 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
|
decreases expression | ISO | 11 | 83,396,028 | 83,408,584 | RGD:6480464 | CTD | |
| G | B3gnt7 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 |
|
multiple interactions | ISO | 9 | 85,069,241 | 85,073,192 | RGD:6480464 | CTD | |
| G | B4galnt1 | beta-1,4-N-acetyl-galactosaminyl transferase 1 |
|
multiple interactions | ISO | 7 | 67,120,782 | 67,127,697 | RGD:6480464 | CTD | |
| G | B4galnt1 | beta-1,4-N-acetyl-galactosaminyl transferase 1 |
|
decreases expression | EXP | 7 | 67,120,782 | 67,127,697 | RGD:6480464 | CTD | |
| G | B4galt1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
|
increases expression | ISO | 5 | 58,196,388 | 58,243,231 | RGD:6480464 | CTD | |
| G | B4galt6 | UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6 |
|
decreases expression | EXP | 18 | 12,421,062 | 12,478,276 | RGD:6480464 | CTD | |
| G | B9d1 | B9 protein domain 1 |
|
multiple interactions | ISO | 10 | 47,665,630 | 47,673,227 | RGD:6480464 | CTD | |
| G | Baat | bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) |
|
decreases expression | ISO | 5 | 66,245,786 | 66,254,757 | RGD:6480464 | CTD | |
| G | Bach1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
|
decreases expression | ISO | 11 | 27,467,207 | 27,500,173 | RGD:6480464 | CTD | |
| G | Bach1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
|
increases expression | ISO | 11 | 27,467,207 | 27,500,173 | RGD:6480464 | CTD | |
| G | Bach2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
|
multiple interactions | ISO | 5 | 48,611,805 | 48,881,943 | RGD:6480464 | CTD | |
| G | Bach2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
|
multiple interactions | ISO | 5 | 48,611,805 | 48,881,943 | RGD:6480464 | CTD | |
| G | Bach2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
|
multiple interactions | ISO | 5 | 48,611,805 | 48,881,943 | RGD:6480464 | CTD | |
| G | Bach2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
|
increases expression | ISO | 5 | 48,611,805 | 48,881,943 | RGD:6480464 | CTD | |
| G | Bach2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
|
decreases expression | ISO | 5 | 48,611,805 | 48,881,943 | RGD:6480464 | CTD | |
| G | Bcl6b | B-cell CLL/lymphoma 6, member B |
|
affects expression | ISO | 10 | 57,063,162 | 57,068,306 | RGD:6480464 | CTD | |
| G | Bcl6b | B-cell CLL/lymphoma 6, member B |
|
increases expression | ISO | 10 | 57,063,162 | 57,068,306 | RGD:6480464 | CTD | |
| G | Bcl6b | B-cell CLL/lymphoma 6, member B |
|
multiple interactions | ISO | 10 | 57,063,162 | 57,068,306 | RGD:6480464 | CTD | |
| G | Bcl7c | B-cell CLL/lymphoma 7C |
|
increases methylation | ISO | 1 | 186,993,655 | 186,997,484 | RGD:6480464 | CTD | |
| G | Bcl9 | B-cell CLL/lymphoma 9 |
|
increases expression | ISO | 2 | 191,991,187 | 191,998,287 | RGD:6480464 | CTD | |
| G | Bclaf1 | BCL2-associated transcription factor 1 |
|
increases expression | EXP | 1 | 15,605,220 | 15,632,005 | RGD:6480464 | CTD | |
| G | Bclaf1 | BCL2-associated transcription factor 1 |
|
multiple interactions | ISO | 1 | 15,605,220 | 15,632,005 | RGD:6480464 | CTD | |
| G | Bco2 | beta-carotene oxygenase 2 |
|
decreases expression | ISO | 8 | 53,892,017 | 53,917,522 | RGD:6480464 | CTD | |
| G | Bcr | breakpoint cluster region |
|
increases expression | ISO | 20 | 13,972,773 | 14,097,816 | RGD:6480464 | CTD | |
| G | Bcs1l | BC1 (ubiquinol-cytochrome c reductase) synthesis-like |
|
multiple interactions | ISO | 9 | 73,939,024 | 73,943,055 | RGD:6480464 | CTD | |
| G | Bcs1l | BC1 (ubiquinol-cytochrome c reductase) synthesis-like |
|
increases expression | ISO | 9 | 73,939,024 | 73,943,055 | RGD:6480464 | CTD | |
| G | Bdh1 | 3-hydroxybutyrate dehydrogenase, type 1 |
|
multiple interactions | ISO | 11 | 71,130,561 | 71,165,695 | RGD:6480464 | CTD | |
| G | Bdh1 | 3-hydroxybutyrate dehydrogenase, type 1 |
|
decreases expression | ISO | 11 | 71,130,561 | 71,165,695 | RGD:6480464 | CTD | |
| G | Bdh1 | 3-hydroxybutyrate dehydrogenase, type 1 |
|
decreases expression | EXP | 11 | 71,130,561 | 71,165,695 | RGD:6480464 | CTD | |
| G | Bdkrb2 | bradykinin receptor B2 |
|
multiple interactions | ISO | 6 | 129,744,781 | 129,748,851 | RGD:6480464 | CTD | |
| G | Bdkrb2 | bradykinin receptor B2 |
|
decreases expression | ISO | 6 | 129,744,781 | 129,748,851 | RGD:6480464 | CTD | |
| G | Bdkrb2 | bradykinin receptor B2 |
|
increases expression | ISO | 6 | 129,744,781 | 129,748,851 | RGD:6480464 | CTD | |
| G | Bdnf | brain-derived neurotrophic factor | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Bdnf | brain-derived neurotrophic factor | affects expression | EXP | RGD:6480464 | CTD | |||||
| G | Becn1 | beclin 1, autophagy related |
|
multiple interactions | ISO | 10 | 90,317,957 | 90,333,329 | RGD:6480464 | CTD | |
| G | Bet1 | Bet1 golgi vesicular membrane trafficking protein |
|
multiple interactions | ISO | 4 | 28,941,105 | 28,951,375 | RGD:6480464 | CTD | |
| G | Bet1l | Bet1 golgi vesicular membrane trafficking protein-like |
|
multiple interactions | ISO | 1 | 201,010,734 | 201,013,527 | RGD:6480464 | CTD | |
| G | Bet1l | Bet1 golgi vesicular membrane trafficking protein-like |
|
increases expression | ISO | 1 | 201,010,734 | 201,013,527 | RGD:6480464 | CTD | |
| G | Bex1 | brain expressed, X-linked 1 |
|
multiple interactions | ISO | X | 123,527,737 | 123,529,133 | RGD:6480464 | CTD | |
| G | Bfar | bifunctional apoptosis regulator |
|
increases expression | ISO | 10 | 49 | 13,315 | RGD:6480464 | CTD | |
| G | Bglap | bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions | ISO | 2 | 180,482,313 | 180,483,290 | RGD:6480464 | CTD | |
| G | Bglap | bone gamma-carboxyglutamate (gla) protein |
|
decreases expression | ISO | 2 | 180,482,313 | 180,483,290 | RGD:6480464 | CTD | |
| G | Bglap | bone gamma-carboxyglutamate (gla) protein |
|
decreases expression | ISO | 2 | 180,482,313 | 180,483,290 | RGD:6480464 | CTD | |
| G | Bglap | bone gamma-carboxyglutamate (gla) protein |
|
decreases expression | ISO | 2 | 180,482,313 | 180,483,290 | RGD:6480464 | CTD | |
| G | Bglap | bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions | ISO | 2 | 180,482,313 | 180,483,290 | RGD:6480464 | CTD | |
| G | Bglap | bone gamma-carboxyglutamate (gla) protein |
|
decreases expression | ISO | 2 | 180,482,313 | 180,483,290 | RGD:6480464 | CTD | |
| G | Bglap | bone gamma-carboxyglutamate (gla) protein |
|
decreases expression | ISO | 2 | 180,482,313 | 180,483,290 | RGD:6480464 | CTD | |
| G | Bglap | bone gamma-carboxyglutamate (gla) protein |
|
decreases expression | EXP | 2 | 180,482,313 | 180,483,290 | RGD:6480464 | CTD | |
| G | Bgn | biglycan |
|
decreases expression | ISO | X | 159,380,557 | 159,393,409 | RGD:6480464 | CTD | |
| G | Bgn | biglycan |
|
increases expression | EXP | X | 159,380,557 | 159,393,409 | RGD:6480464 | CTD | |
| G | Bhlha15 | basic helix-loop-helix family, member a15 |
|
multiple interactions | ISO | 12 | 10,747,865 | 10,752,041 | RGD:6480464 | CTD | |
| G | Bhlha15 | basic helix-loop-helix family, member a15 |
|
increases expression | ISO | 12 | 10,747,865 | 10,752,041 | RGD:6480464 | CTD | |
| G | Bhlhe40 | basic helix-loop-helix family, member e40 |
|
decreases expression | ISO | 4 | 144,139,486 | 144,145,186 | RGD:6480464 | CTD | |
| G | Bhlhe40 | basic helix-loop-helix family, member e40 |
|
decreases expression | ISO | 4 | 144,139,486 | 144,145,186 | RGD:6480464 | CTD | |
| G | Bhlhe40 | basic helix-loop-helix family, member e40 |
|
increases expression | EXP | 4 | 144,139,486 | 144,145,186 | RGD:6480464 | CTD | |
| G | Bhlhe40 | basic helix-loop-helix family, member e40 |
|
increases expression | ISO | 4 | 144,139,486 | 144,145,186 | RGD:6480464 | CTD | |
| G | Bhmt | betaine-homocysteine S-methyltransferase |
|
decreases expression | EXP | 2 | 23,923,651 | 23,943,320 | RGD:6480464 | CTD | |
| G | Bhmt | betaine-homocysteine S-methyltransferase |
|
increases expression | EXP | 2 | 23,923,651 | 23,943,320 | RGD:6480464 | CTD | |
| G | Bhmt2 | betaine-homocysteine S-methyltransferase 2 |
|
multiple interactions | ISO | 2 | 23,958,062 | 23,976,438 | RGD:6480464 | CTD | |
| G | Bhmt2 | betaine-homocysteine S-methyltransferase 2 |
|
increases expression | EXP | 2 | 23,958,062 | 23,976,438 | RGD:6480464 | CTD | |
| G | Bicc1 | bicaudal C homolog 1 (Drosophila) |
|
increases expression | ISO | 20 | 18,288,079 | 18,477,016 | RGD:6480464 | CTD | |
| G | Bicd2 | bicaudal D homolog 2 (Drosophila) |
|
increases expression | ISO | 17 | 21,214,977 | 21,260,729 | RGD:6480464 | CTD | |
| G | Bicd2 | bicaudal D homolog 2 (Drosophila) |
|
increases expression | ISO | 17 | 21,214,977 | 21,260,729 | RGD:6480464 | CTD | |
| G | Bicd2 | bicaudal D homolog 2 (Drosophila) |
|
multiple interactions | ISO | 17 | 21,214,977 | 21,260,729 | RGD:6480464 | CTD | |
| G | Bid | BH3 interacting domain death agonist |
|
increases cleavage | ISO | 4 | 157,296,383 | 157,318,481 | RGD:6480464 | CTD | |
| G | Bmp2k | BMP-2 inducible kinase |
|
multiple interactions | ISO | 14 | 13,937,544 | 14,001,748 | RGD:6480464 | CTD | |
| G | Brca1 | breast cancer 1, early onset |
|
multiple interactions | ISO | 10 | 90,513,630 | 90,572,676 | RGD:6480464 | CTD | |
| G | Brca2 | breast cancer 2, early onset |
|
increases expression | ISO | 12 | 4,282,952 | 4,323,693 | RGD:6480464 | CTD | |
| G | Brcc3 | BRCA1/BRCA2-containing complex, subunit 3 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Brd2 | bromodomain containing 2 |
|
multiple interactions | ISO | 20 | 4,864,606 | 4,871,813 | RGD:6480464 | CTD | |
| G | Brd2 | bromodomain containing 2 |
|
affects expression | ISO | 20 | 4,864,606 | 4,871,813 | RGD:6480464 | CTD | |
| G | Brd3 | bromodomain containing 3 |
|
multiple interactions | ISO | 3 | 6,369,903 | 6,390,116 | RGD:6480464 | CTD | |
| G | Brd7 | bromodomain containing 7 |
|
multiple interactions | ISO | 19 | 20,019,637 | 20,048,264 | RGD:6480464 | CTD | |
| G | Brd8 | bromodomain containing 8 |
|
multiple interactions | ISO | 18 | 27,074,235 | 27,094,586 | RGD:6480464 | CTD | |
| G | Bre | brain and reproductive organ-expressed (TNFRSF1A modulator) |
|
increases expression | ISO | 6 | 24,406,837 | 24,791,918 | RGD:6480464 | CTD | |
| G | Bre | brain and reproductive organ-expressed (TNFRSF1A modulator) |
|
increases expression | EXP | 6 | 24,406,837 | 24,791,918 | RGD:6480464 | CTD | |
| G | Brf1 | BRF1 homolog, subunit of RNA polymerase III transcription initiation factor IIIB (S. cerevisiae) |
|
multiple interactions | ISO | 6 | 137,962,953 | 138,007,641 | RGD:6480464 | CTD | |
| G | Bri3 | brain protein I3 |
|
decreases expression | EXP | 12 | 10,670,023 | 10,678,698 | RGD:6480464 | CTD | |
| G | Bri3bp | Bri3 binding protein |
|
multiple interactions | ISO | 12 | 32,270,907 | 32,282,728 | RGD:6480464 | CTD | |
| G | Brip1 | BRCA1 interacting protein C-terminal helicase 1 |
|
decreases expression | ISO | 10 | 74,313,004 | 74,436,532 | RGD:6480464 | CTD | |
| G | Brix1 | BRX1, biogenesis of ribosomes, homolog (S. cerevisiae) |
|
decreases expression | ISO | 2 | 59,826,894 | 59,837,772 | RGD:6480464 | CTD | |
| G | Brms1 | breast cancer metastasis-suppressor 1 |
|
multiple interactions | ISO | 1 | 207,661,537 | 207,670,801 | RGD:6480464 | CTD | |
| G | Brpf1 | bromodomain and PHD finger containing, 1 |
|
multiple interactions | ISO | 4 | 149,191,088 | 149,207,605 | RGD:6480464 | CTD | |
| G | Bsn | bassoon (presynaptic cytomatrix protein) |
|
increases expression | ISO | 8 | 113,364,208 | 113,455,766 | RGD:6480464 | CTD | |
| G | Bst1 | bone marrow stromal cell antigen 1 |
|
decreases expression | ISO | 14 | 72,404,263 | 72,414,500 | RGD:6480464 | CTD | |
| G | Bst1 | bone marrow stromal cell antigen 1 |
|
multiple interactions | ISO | 14 | 72,404,263 | 72,414,500 | RGD:6480464 | CTD | |
| G | Bst1 | bone marrow stromal cell antigen 1 |
|
increases expression | ISO | 14 | 72,404,263 | 72,414,500 | RGD:6480464 | CTD | |
| G | Bst2 | bone marrow stromal cell antigen 2 |
|
multiple interactions | ISO | 16 | 18,698,545 | 18,701,768 | RGD:6480464 | CTD | |
| G | Bst2 | bone marrow stromal cell antigen 2 |
|
increases expression | ISO | 16 | 18,698,545 | 18,701,768 | RGD:6480464 | CTD | |
| G | Bst2 | bone marrow stromal cell antigen 2 |
|
decreases expression | ISO | 16 | 18,698,545 | 18,701,768 | RGD:6480464 | CTD | |
| G | Btaf1 | BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, (Mot1 homolog, S. cerevisiae) |
|
increases expression | ISO | 1 | 241,212,431 | 241,287,889 | RGD:6480464 | CTD | |
| G | Btbd11 | BTB (POZ) domain containing 11 |
|
decreases expression | ISO | 7 | 20,173,338 | 20,289,415 | RGD:6480464 | CTD | |
| G | Btbd11 | BTB (POZ) domain containing 11 |
|
increases expression | ISO | 7 | 20,173,338 | 20,289,415 | RGD:6480464 | CTD | |
| G | Btbd11 | BTB (POZ) domain containing 11 |
|
multiple interactions | ISO | 7 | 20,173,338 | 20,289,415 | RGD:6480464 | CTD | |
| G | Btbd6 | BTB (POZ) domain containing 6 |
|
decreases expression | ISO | 6 | 137,983,974 | 137,986,434 | RGD:6480464 | CTD | |
| G | Btbd9 | BTB (POZ) domain containing 9 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Btc | betacellulin |
|
decreases expression | ISO | 14 | 18,194,470 | 18,235,228 | RGD:6480464 | CTD | |
| G | Btf3 | basic transcription factor 3 |
|
affects expression | ISO | 2 | 28,900,451 | 28,907,561 | RGD:6480464 | CTD | |
| G | Btf3l4 | basic transcription factor 3-like 4 |
|
increases expression | ISO | 5 | 130,123,334 | 130,142,207 | RGD:6480464 | CTD | |
| G | Btg1 | B-cell translocation gene 1, anti-proliferative |
|
multiple interactions | ISO | 7 | 34,029,300 | 34,031,557 | RGD:6480464 | CTD | |
| G | Btg1 | B-cell translocation gene 1, anti-proliferative |
|
increases expression | ISO | 7 | 34,029,300 | 34,031,557 | RGD:6480464 | CTD | |
| G | Btg1 | B-cell translocation gene 1, anti-proliferative |
|
increases expression | EXP | 7 | 34,029,300 | 34,031,557 | RGD:6480464 | CTD | |
| G | Btg2 | BTG family, member 2 |
|
multiple interactions | ISO | 13 | 47,026,986 | 47,030,745 | RGD:6480464 | CTD | |
| G | Btg2 | BTG family, member 2 |
|
affects expression | ISO | 13 | 47,026,986 | 47,030,745 | RGD:6480464 | CTD | |
| G | Btg2 | BTG family, member 2 |
|
increases expression | ISO | 13 | 47,026,986 | 47,030,745 | RGD:6480464 | CTD | |
| G | Btk | Bruton agammaglobulinemia tyrosine kinase |
|
multiple interactions | ISO | X | 121,998,935 | 122,030,289 | RGD:6480464 | CTD | |
| G | Bub1 | BUB1 mitotic checkpoint serine/threonine kinase |
|
multiple interactions | ISO | 3 | 115,323,510 | 115,354,906 | RGD:6480464 | CTD | |
| G | Bub1 | BUB1 mitotic checkpoint serine/threonine kinase |
|
increases expression | ISO | 3 | 115,323,510 | 115,354,906 | RGD:6480464 | CTD | |
| G | Bub1b | BUB1 mitotic checkpoint serine/threonine kinase B |
|
multiple interactions | ISO | 3 | 105,063,018 | 105,116,145 | RGD:6480464 | CTD | |
| G | Bub3 | budding uninhibited by benzimidazoles 3 homolog (S. cerevisiae) |
|
decreases expression | ISO | 1 | 191,128,891 | 191,139,401 | RGD:6480464 | CTD | |
| G | Bucs1 | butyryl Coenzyme A synthetase 1 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | C1qtnf4 | C1q and tumor necrosis factor related protein 4 |
|
multiple interactions | ISO | 3 | 75,248,277 | 75,252,715 | RGD:6480464 | CTD | |
| G | C4bpa | complement component 4 binding protein, alpha |
|
decreases expression | ISO | 13 | 43,552,947 | 43,588,565 | RGD:6480464 | CTD | |
| G | C5 | complement component 5 |
|
decreases expression | ISO | 3 | 14,011,115 | 14,102,744 | RGD:6480464 | CTD | |
| G | C5 | complement component 5 |
|
increases expression | ISO | 3 | 14,011,115 | 14,102,744 | RGD:6480464 | CTD | |
| G | C5ar1 | complement component 5a receptor 1 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | C6 | complement component 6 |
|
decreases expression | ISO | 2 | 53,691,290 | 53,764,539 | RGD:6480464 | CTD | |
| G | C6 | complement component 6 |
|
multiple interactions | ISO | 2 | 53,691,290 | 53,764,539 | RGD:6480464 | CTD | |
| G | C8g | complement component 8, gamma polypeptide |
|
affects expression | ISO | 3 | 3,671,282 | 3,674,282 | RGD:6480464 | CTD | |
| G | C8g | complement component 8, gamma polypeptide |
|
increases expression | ISO | 3 | 3,671,282 | 3,674,282 | RGD:6480464 | CTD | |
| G | Ca2 | carbonic anhydrase 2 |
|
increases expression | EXP | 2 | 88,077,095 | 88,092,223 | RGD:6480464 | CTD | |
| G | Ca2 | carbonic anhydrase 2 |
|
multiple interactions | ISO | 2 | 88,077,095 | 88,092,223 | RGD:6480464 | CTD | |
| G | Ca2 | carbonic anhydrase 2 |
|
decreases expression | EXP | 2 | 88,077,095 | 88,092,223 | RGD:6480464 | CTD | |
| G | Ca2 | carbonic anhydrase 2 |
|
decreases expression | ISO | 2 | 88,077,095 | 88,092,223 | RGD:6480464 | CTD | |
| G | Cab39l | calcium binding protein 39-like |
|
multiple interactions | ISO | 15 | 38,552,234 | 38,640,594 | RGD:6480464 | CTD | |
| G | Cabin1 | calcineurin binding protein 1 |
|
multiple interactions | ISO | 20 | 13,444,801 | 13,569,453 | RGD:6480464 | CTD | |
| G | Cabyr | calcium binding tyrosine-(Y)-phosphorylation regulated | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Cabyr | calcium binding tyrosine-(Y)-phosphorylation regulated | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Cabyr | calcium binding tyrosine-(Y)-phosphorylation regulated | decreases expression | ISO | RGD:6480464 | CTD | |||||
| G | Cacna1c | calcium channel, voltage-dependent, L type, alpha 1C subunit |
|
decreases expression | ISO | 4 | 154,895,691 | 155,517,389 | RGD:6480464 | CTD | |
| G | Cacna1d | calcium channel, voltage-dependent, L type, alpha 1D subunit |
|
multiple interactions | ISO | 16 | 5,383,259 | 5,703,361 | RGD:6480464 | CTD | |
| G | Cacna1d | calcium channel, voltage-dependent, L type, alpha 1D subunit |
|
increases expression | ISO | 16 | 5,383,259 | 5,703,361 | RGD:6480464 | CTD | |
| G | Cacna1g | calcium channel, voltage-dependent, T type, alpha 1G subunit |
|
multiple interactions | ISO | 10 | 83,043,636 | 83,112,886 | RGD:6480464 | CTD | |
| G | Cacna1s | calcium channel, voltage-dependent, L type, alpha 1S subunit | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Cacnb2 | calcium channel, voltage-dependent, beta 2 subunit |
|
decreases expression | ISO | 17 | 88,832,905 | 89,078,870 | RGD:6480464 | CTD | |
| G | Cacng4 | calcium channel, voltage-dependent, gamma subunit 4 |
|
decreases expression | ISO | 10 | 97,139,397 | 97,214,444 | RGD:6480464 | CTD | |
| G | Cacng4 | calcium channel, voltage-dependent, gamma subunit 4 |
|
multiple interactions | ISO | 10 | 97,139,397 | 97,214,444 | RGD:6480464 | CTD | |
| G | Cacybp | calcyclin binding protein |
|
multiple interactions | ISO | 13 | 75,623,161 | 75,633,644 | RGD:6480464 | CTD | |
| G | Cacybp | calcyclin binding protein |
|
decreases expression | ISO | 13 | 75,623,161 | 75,633,644 | RGD:6480464 | CTD | |
| G | Camk1d | calcium/calmodulin-dependent protein kinase ID |
|
multiple interactions | ISO | 17 | 83,649,720 | 84,061,160 | RGD:6480464 | CTD | |
| G | Capn12 | calpain 12 |
|
multiple interactions | ISO | 1 | 83,989,000 | 84,001,059 | RGD:6480464 | CTD | |
| G | Capza1 | capping protein (actin filament) muscle Z-line, alpha 1 |
|
multiple interactions | ISO | 2 | 200,080,802 | 200,125,881 | RGD:6480464 | CTD | |
| G | Car11 | carbonic anhydrase 11 |
|
multiple interactions | ISO | 1 | 96,167,823 | 96,172,934 | RGD:6480464 | CTD | |
| G | Car11 | carbonic anhydrase 11 |
|
decreases expression | ISO | 1 | 96,167,823 | 96,172,934 | RGD:6480464 | CTD | |
| G | Car12 | carbonic anyhydrase 12 |
|
increases expression | ISO | 8 | 71,017,732 | 71,070,729 | RGD:6480464 | CTD | |
| G | Car12 | carbonic anyhydrase 12 |
|
multiple interactions | ISO | 8 | 71,017,732 | 71,070,729 | RGD:6480464 | CTD | |
| G | Car14 | carbonic anhydrase 14 |
|
decreases expression | ISO | 2 | 190,683,916 | 190,690,229 | RGD:6480464 | CTD | |
| G | Car3 | carbonic anhydrase 3 |
|
affects expression | ISO | 2 | 88,106,727 | 88,114,686 | RGD:6480464 | CTD | |
| G | Car3 | carbonic anhydrase 3 |
|
multiple interactions | ISO | 2 | 88,106,727 | 88,114,686 | RGD:6480464 | CTD | |
| G | Car3 | carbonic anhydrase 3 |
|
decreases expression | ISO | 2 | 88,106,727 | 88,114,686 | RGD:6480464 | CTD | |
| G | Car3 | carbonic anhydrase 3 |
|
decreases expression | EXP | 2 | 88,106,727 | 88,114,686 | RGD:6480464 | CTD | |
| G | Car3 | carbonic anhydrase 3 |
|
decreases expression | EXP | 2 | 88,106,727 | 88,114,686 | RGD:6480464 | CTD | |
| G | Car3 | carbonic anhydrase 3 |
|
decreases expression | EXP | 2 | 88,106,727 | 88,114,686 | RGD:6480464 | CTD | |
| G | Car5b | carbonic anhydrase 5b, mitochondrial |
|
multiple interactions | ISO | X | 51,241,437 | 51,290,433 | RGD:6480464 | CTD | |
| G | Car8 | carbonic anhydrase 8 |
|
affects expression | ISO | 5 | 21,951,255 | 22,049,427 | RGD:6480464 | CTD | |
| G | Car9 | carbonic anhydrase 9 |
|
multiple interactions | ISO | 5 | 59,986,413 | 59,993,015 | RGD:6480464 | CTD | |
| G | Car9 | carbonic anhydrase 9 |
|
multiple interactions | ISO | 5 | 59,986,413 | 59,993,015 | RGD:6480464 | CTD | |
| G | Card10 | caspase recruitment domain family, member 10 |
|
increases expression | ISO | 7 | 116,737,928 | 116,766,959 | RGD:6480464 | CTD | |
| G | Card10 | caspase recruitment domain family, member 10 |
|
decreases expression | ISO | 7 | 116,737,928 | 116,766,959 | RGD:6480464 | CTD | |
| G | Card10 | caspase recruitment domain family, member 10 |
|
multiple interactions | ISO | 7 | 116,737,928 | 116,766,959 | RGD:6480464 | CTD | |
| G | Card6 | caspase recruitment domain family, member 6 |
|
increases expression | EXP | 2 | 54,282,217 | 54,293,630 | RGD:6480464 | CTD | |
| G | Carhsp1 | calcium regulated heat stable protein 1 |
|
multiple interactions | ISO | 10 | 6,986,583 | 7,000,181 | RGD:6480464 | CTD | |
| G | Carhsp1 | calcium regulated heat stable protein 1 |
|
decreases expression | ISO | 10 | 6,986,583 | 7,000,181 | RGD:6480464 | CTD | |
| G | Cars | cysteinyl-tRNA synthetase |
|
multiple interactions | ISO | 1 | 203,934,812 | 203,977,042 | RGD:6480464 | CTD | |
| G | Cartpt | CART prepropeptide |
|
multiple interactions | EXP | 2 | 30,889,817 | 30,891,837 | RGD:6480464 | CTD | |
| G | Cartpt | CART prepropeptide |
|
increases expression | EXP | 2 | 30,889,817 | 30,891,837 | RGD:6480464 | CTD | |
| G | Casc3 | cancer susceptibility candidate 3 |
|
increases expression | EXP | 10 | 87,581,850 | 87,602,528 | RGD:6480464 | CTD | |
| G | Casp1 | caspase 1 |
|
multiple interactions | ISO | 8 | 2,027,976 | 2,036,872 | RGD:6480464 | CTD | |
| G | Casp1 | caspase 1 |
|
decreases expression | ISO | 8 | 2,027,976 | 2,036,872 | RGD:6480464 | CTD | |
| G | Casp1 | caspase 1 |
|
multiple interactions | ISO | 8 | 2,027,976 | 2,036,872 | RGD:6480464 | CTD | |
| G | Casp1 | caspase 1 |
|
multiple interactions | ISO | 8 | 2,027,976 | 2,036,872 | RGD:6480464 | CTD | |
| G | Casp1 | caspase 1 |
|
increases expression | ISO | 8 | 2,027,976 | 2,036,872 | RGD:6480464 | CTD | |
| G | Casp1 | caspase 1 |
|
increases expression | EXP | 8 | 2,027,976 | 2,036,872 | RGD:6480464 | CTD | |
| G | Casp1 | caspase 1 |
|
increases expression | ISO | 8 | 2,027,976 | 2,036,872 | RGD:6480464 | CTD | |
| G | Casp14 | caspase 14 |
|
increases expression | EXP | 7 | 12,487,166 | 12,489,998 | RGD:6480464 | CTD | |
| G | Casp14 | caspase 14 |
|
increases expression | ISO | 7 | 12,487,166 | 12,489,998 | RGD:6480464 | CTD | |
| G | Casp2 | caspase 2 |
|
multiple interactions | ISO | 4 | 70,029,728 | 70,047,164 | RGD:6480464 | CTD | |
| G | Casp2 | caspase 2 |
|
increases expression | ISO | 4 | 70,029,728 | 70,047,164 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
increases activity | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
multiple interactions | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
increases expression | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
decreases expression | EXP | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
increases expression | EXP | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
increases activity | EXP | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp4 | caspase 4, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 8 | 2,038,626 | 2,075,722 | RGD:6480464 | CTD | |
| G | Casp4 | caspase 4, apoptosis-related cysteine peptidase |
|
increases expression | ISO | 8 | 2,038,626 | 2,075,722 | RGD:6480464 | CTD | |
| G | Casp4 | caspase 4, apoptosis-related cysteine peptidase |
|
increases expression | ISO | 8 | 2,038,626 | 2,075,722 | RGD:6480464 | CTD | |
| G | Casp6 | caspase 6 |
|
increases expression | ISO | 2 | 227,361,538 | 227,373,844 | RGD:6480464 | CTD | |
| G | Cbx1 | chromobox homolog 1 |
|
multiple interactions | ISO | 10 | 85,544,537 | 85,564,903 | RGD:6480464 | CTD | |
| G | Cbx1 | chromobox homolog 1 |
|
increases expression | ISO | 10 | 85,544,537 | 85,564,903 | RGD:6480464 | CTD | |
| G | Ccl1 | chemokine (C-C motif) ligand 1 |
|
multiple interactions | ISO | 10 | 70,380,498 | 70,383,276 | RGD:6480464 | CTD | |
| G | Ccl1 | chemokine (C-C motif) ligand 1 |
|
increases expression | ISO | 10 | 70,380,498 | 70,383,276 | RGD:6480464 | CTD | |
| G | Ccl1 | chemokine (C-C motif) ligand 1 |
|
increases expression | ISO | 10 | 70,380,498 | 70,383,276 | RGD:6480464 | CTD | |
| G | Ccl1 | chemokine (C-C motif) ligand 1 |
|
increases expression | ISO | 10 | 70,380,498 | 70,383,276 | RGD:6480464 | CTD | |
| G | Ccl11 | chemokine (C-C motif) ligand 11 |
|
multiple interactions | ISO | 10 | 70,279,161 | 70,283,762 | RGD:6480464 | CTD | |
| G | Ccl17 | chemokine (C-C motif) ligand 17 |
|
multiple interactions | ISO | 19 | 10,641,376 | 10,642,827 | RGD:6480464 | CTD | |
| G | Ccl17 | chemokine (C-C motif) ligand 17 |
|
increases expression | ISO | 19 | 10,641,376 | 10,642,827 | RGD:6480464 | CTD | |
| G | Ccl2 | chemokine (C-C motif) ligand 2 |
|
multiple interactions | ISO | 10 | 70,256,263 | 70,258,061 | RGD:6480464 | CTD | |
| G | Ccl2 | chemokine (C-C motif) ligand 2 |
|
increases expression | ISO | 10 | 70,256,263 | 70,258,061 | RGD:6480464 | CTD | |
| G | Ccl2 | chemokine (C-C motif) ligand 2 |
|
multiple interactions | ISO | 10 | 70,256,263 | 70,258,061 | RGD:6480464 | CTD | |
| G | Ccl2 | chemokine (C-C motif) ligand 2 |
|
decreases expression | ISO | 10 | 70,256,263 | 70,258,061 | RGD:6480464 | CTD | |
| G | Ccl2 | chemokine (C-C motif) ligand 2 |
|
increases expression | ISO | 10 | 70,256,263 | 70,258,061 | RGD:6480464 | CTD | |
| G | Ccl20 | chemokine (C-C motif) ligand 20 |
|
increases expression | ISO | 9 | 82,440,965 | 82,443,542 | RGD:6480464 | CTD | |
| G | Ccl20 | chemokine (C-C motif) ligand 20 |
|
increases expression | ISO | 9 | 82,440,965 | 82,443,542 | RGD:6480464 | CTD | |
| G | Ccl21 | chemokine (C-C motif) ligand 21 |
|
multiple interactions | ISO | 5 | 59,238,897 | 59,240,001 | RGD:6480464 | CTD | |
| G | Ccl21 | chemokine (C-C motif) ligand 21 |
|
decreases expression | ISO | 5 | 59,238,897 | 59,240,001 | RGD:6480464 | CTD | |
| G | Ccl5 | chemokine (C-C motif) ligand 5 |
|
multiple interactions | ISO | 10 | 71,605,791 | 71,610,330 | RGD:6480464 | CTD | |
| G | Ccl5 | chemokine (C-C motif) ligand 5 |
|
multiple interactions | ISO | 10 | 71,605,791 | 71,610,330 | RGD:6480464 | CTD | |
| G | Ccl5 | chemokine (C-C motif) ligand 5 |
|
increases expression | ISO | 10 | 71,605,791 | 71,610,330 | RGD:6480464 | CTD | |
| G | Ccl5 | chemokine (C-C motif) ligand 5 |
|
multiple interactions | ISO | 10 | 71,605,791 | 71,610,330 | RGD:6480464 | CTD | |
| G | Ccl5 | chemokine (C-C motif) ligand 5 |
|
decreases expression | ISO | 10 | 71,605,791 | 71,610,330 | RGD:6480464 | CTD | |
| G | Ccl5 | chemokine (C-C motif) ligand 5 |
|
decreases expression | EXP | 10 | 71,605,791 | 71,610,330 | RGD:6480464 | CTD | |
| G | Ccl6 | chemokine (C-C motif) ligand 6 |
|
decreases expression | ISO | 10 | 71,660,623 | 71,665,255 | RGD:6480464 | CTD | |
| G | Ccl7 | chemokine (C-C motif) ligand 7 |
|
multiple interactions | ISO | 10 | 70,267,281 | 70,269,131 | RGD:6480464 | CTD | |
| G | Ccl7 | chemokine (C-C motif) ligand 7 |
|
decreases expression | ISO | 10 | 70,267,281 | 70,269,131 | RGD:6480464 | CTD | |
| G | Ccl9 | chemokine (C-C motif) ligand 9 |
|
increases expression | ISO | 10 | 71,645,931 | 71,650,814 | RGD:6480464 | CTD | |
| G | Ccl9 | chemokine (C-C motif) ligand 9 |
|
decreases expression | ISO | 10 | 71,645,931 | 71,650,814 | RGD:6480464 | CTD | |
| G | Ccna2 | cyclin A2 |
|
multiple interactions | ISO | 2 | 123,062,752 | 123,069,085 | RGD:6480464 | CTD | |
| G | Ccna2 | cyclin A2 |
|
decreases expression | ISO | 2 | 123,062,752 | 123,069,085 | RGD:6480464 | CTD | |
| G | Ccna2 | cyclin A2 |
|
increases expression | ISO | 2 | 123,062,752 | 123,069,085 | RGD:6480464 | CTD | |
| G | Ccna2 | cyclin A2 |
|
multiple interactions | EXP | 2 | 123,062,752 | 123,069,085 | RGD:6480464 | CTD | |
| G | Ccna2 | cyclin A2 |
|
increases expression | EXP | 2 | 123,062,752 | 123,069,085 | RGD:6480464 | CTD | |
| G | Ccnb1 | cyclin B1 |
|
multiple interactions | ISO | 2 | 31,574,600 | 31,581,784 | RGD:6480464 | CTD | |
| G | Ccnb1 | cyclin B1 |
|
decreases expression | ISO | 2 | 31,574,600 | 31,581,784 | RGD:6480464 | CTD | |
| G | Ccnb1 | cyclin B1 |
|
increases expression | ISO | 2 | 31,574,600 | 31,581,784 | RGD:6480464 | CTD | |
| G | Ccnb2 | cyclin B2 |
|
increases expression | ISO | 8 | 74,892,108 | 74,906,181 | RGD:6480464 | CTD | |
| G | Ccnb2 | cyclin B2 |
|
decreases expression | ISO | 8 | 74,892,108 | 74,906,181 | RGD:6480464 | CTD | |
| G | Ccnb2 | cyclin B2 |
|
multiple interactions | ISO | 8 | 74,892,108 | 74,906,181 | RGD:6480464 | CTD | |
| G | Ccnc | cyclin C |
|
decreases expression | ISO | 5 | 36,465,490 | 36,483,538 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
affects expression | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
decreases expression | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
decreases expression | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
multiple interactions | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
multiple interactions | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Cd14 | CD14 molecule |
|
decreases expression | ISO | 18 | 29,374,593 | 29,376,190 | RGD:6480464 | CTD | |
| G | Cd160 | CD160 molecule |
|
increases expression | ISO | 2 | 191,611,172 | 191,619,320 | RGD:6480464 | CTD | |
| G | Cd164 | CD164 molecule, sialomucin |
|
multiple interactions | ISO | 20 | 45,486,590 | 45,498,166 | RGD:6480464 | CTD | |
| G | Cd200 | Cd200 molecule |
|
multiple interactions | ISO | 11 | 56,946,504 | 56,974,256 | RGD:6480464 | CTD | |
| G | Cd22 | CD22 molecule |
|
multiple interactions | ISO | 1 | 85,923,707 | 85,938,567 | RGD:6480464 | CTD | |
| G | Cd24 | CD24 molecule |
|
decreases expression | ISO | 20 | 47,502,354 | 47,507,663 | RGD:6480464 | CTD | |
| G | Cd24 | CD24 molecule |
|
multiple interactions | ISO | 20 | 47,502,354 | 47,507,663 | RGD:6480464 | CTD | |
| G | Cd24 | CD24 molecule |
|
decreases expression | ISO | 20 | 47,502,354 | 47,507,663 | RGD:6480464 | CTD | |
| G | Cd24 | CD24 molecule |
|
decreases expression | ISO | 20 | 47,502,354 | 47,507,663 | RGD:6480464 | CTD | |
| G | Cd24 | CD24 molecule |
|
increases expression | ISO | 20 | 47,502,354 | 47,507,663 | RGD:6480464 | CTD | |
| G | Cd248 | CD248 molecule, endosialin |
|
increases expression | ISO | 1 | 207,689,953 | 207,692,517 | RGD:6480464 | CTD | |
| G | Cd276 | Cd276 molecule |
|
increases expression | ISO | 8 | 62,331,017 | 62,361,346 | RGD:6480464 | CTD | |
| G | Cd28 | Cd28 molecule |
|
decreases expression | ISO | 9 | 59,342,273 | 59,367,743 | RGD:6480464 | CTD | |
| G | Cd28 | Cd28 molecule |
|
increases expression | ISO | 9 | 59,342,273 | 59,367,743 | RGD:6480464 | CTD | |
| G | Cd2bp2 | Cd2 (cytoplasmic tail) binding protein 2 |
|
multiple interactions | ISO | 1 | 186,451,415 | 186,455,407 | RGD:6480464 | CTD | |
| G | Cd302 | CD302 molecule |
|
affects expression | ISO | 3 | 41,958,036 | 41,991,705 | RGD:6480464 | CTD | |
| G | Cd36 | CD36 molecule (thrombospondin receptor) |
|
decreases expression | ISO | 4 | 13,471,878 | 13,525,620 | RGD:6480464 | CTD | |
| G | Cd36 | CD36 molecule (thrombospondin receptor) |
|
increases expression | ISO | 4 | 13,471,878 | 13,525,620 | RGD:6480464 | CTD | |
| G | Cd36 | CD36 molecule (thrombospondin receptor) |
|
multiple interactions | ISO | 4 | 13,471,878 | 13,525,620 | RGD:6480464 | CTD | |
| G | Cd36 | CD36 molecule (thrombospondin receptor) |
|
affects expression | ISO | 4 | 13,471,878 | 13,525,620 | RGD:6480464 | CTD | |
| G | Cd36 | CD36 molecule (thrombospondin receptor) |
|
multiple interactions | ISO | 4 | 13,471,878 | 13,525,620 | RGD:6480464 | CTD | |
| G | Cd36 | CD36 molecule (thrombospondin receptor) |
|
increases expression | ISO | 4 | 13,471,878 | 13,525,620 | RGD:6480464 | CTD | |
| G | Cd36 | CD36 molecule (thrombospondin receptor) |
|
decreases expression | ISO | 4 | 13,471,878 | 13,525,620 | RGD:6480464 | CTD | |
| G | Cd38 | CD38 molecule |
|
increases expression | ISO | 14 | 72,320,479 | 72,360,329 | RGD:6480464 | CTD | |
| G | Cd38 | CD38 molecule |
|
multiple interactions | ISO | 14 | 72,320,479 | 72,360,329 | RGD:6480464 | CTD | |
| G | Cd3d | CD3 molecule, delta |
|
affects expression | ISO | 8 | 47,932,151 | 47,936,744 | RGD:6480464 | CTD | |
| G | Cd3d | CD3 molecule, delta |
|
multiple interactions | ISO | 8 | 47,932,151 | 47,936,744 | RGD:6480464 | CTD | |
| G | Cd3d | CD3 molecule, delta |
|
decreases expression | ISO | 8 | 47,932,151 | 47,936,744 | RGD:6480464 | CTD | |
| G | Cd3e | CD3 molecule, epsilon |
|
multiple interactions | ISO | 8 | 47,947,257 | 47,958,419 | RGD:6480464 | CTD | |
| G | Cd3e | CD3 molecule, epsilon |
|
decreases expression | ISO | 8 | 47,947,257 | 47,958,419 | RGD:6480464 | CTD | |
| G | Cd3e | CD3 molecule, epsilon |
|
multiple interactions | ISO | 8 | 47,947,257 | 47,958,419 | RGD:6480464 | CTD | |
| G | Cd3e | CD3 molecule, epsilon |
|
increases expression | ISO | 8 | 47,947,257 | 47,958,419 | RGD:6480464 | CTD | |
| G | Cd4 | Cd4 molecule |
|
multiple interactions | ISO | 4 | 160,988,512 | 161,014,038 | RGD:6480464 | CTD | |
| G | Cd4 | Cd4 molecule |
|
multiple interactions | ISO | 4 | 160,988,512 | 161,014,038 | RGD:6480464 | CTD | |
| G | Cd4 | Cd4 molecule |
|
decreases expression | ISO | 4 | 160,988,512 | 161,014,038 | RGD:6480464 | CTD | |
| G | Cd40 | CD40 molecule, TNF receptor superfamily member 5 |
|
increases expression | ISO | 3 | 156,092,602 | 156,107,427 | RGD:6480464 | CTD | |
| G | Cd40 | CD40 molecule, TNF receptor superfamily member 5 |
|
increases expression | EXP | 3 | 156,092,602 | 156,107,427 | RGD:6480464 | CTD | |
| G | Cd40lg | CD40 ligand |
|
decreases response to substance | ISO | X | 141,925,019 | 141,937,183 | RGD:6480464 | CTD | |
| G | Cd40lg | CD40 ligand |
|
increases expression | EXP | X | 141,925,019 | 141,937,183 | RGD:6480464 | CTD | |
| G | Cd40lg | CD40 ligand |
|
decreases response to substance | ISO | X | 141,925,019 | 141,937,183 | RGD:6480464 | CTD | |
| G | Cd44 | Cd44 molecule |
|
increases expression | ISO | 3 | 88,022,962 | 88,110,352 | RGD:6480464 | CTD | |
| G | Cd44 | Cd44 molecule |
|
multiple interactions | ISO | 3 | 88,022,962 | 88,110,352 | RGD:6480464 | CTD | |
| G | Cd44 | Cd44 molecule |
|
multiple interactions | ISO | 3 | 88,022,962 | 88,110,352 | RGD:6480464 | CTD | |
| G | Cd44 | Cd44 molecule |
|
multiple interactions | ISO | 3 | 88,022,962 | 88,110,352 | RGD:6480464 | CTD | |
| G | Cd44 | Cd44 molecule |
|
increases expression | ISO | 3 | 88,022,962 | 88,110,352 | RGD:6480464 | CTD | |
| G | Cd44 | Cd44 molecule |
|
increases expression | ISO | 3 | 88,022,962 | 88,110,352 | RGD:6480464 | CTD | |
| G | Cd47 | Cd47 molecule |
|
multiple interactions | ISO | 11 | 52,098,355 | 52,158,169 | RGD:6480464 | CTD | |
| G | Cd47 | Cd47 molecule |
|
increases expression | ISO | 11 | 52,098,355 | 52,158,169 | RGD:6480464 | CTD | |
| G | Cd47 | Cd47 molecule |
|
decreases expression | ISO | 11 | 52,098,355 | 52,158,169 | RGD:6480464 | CTD | |
| G | Cd47 | Cd47 molecule |
|
decreases expression | ISO | 11 | 52,098,355 | 52,158,169 | RGD:6480464 | CTD | |
| G | Cd47 | Cd47 molecule |
|
increases expression | EXP | 11 | 52,098,355 | 52,158,169 | RGD:6480464 | CTD | |
| G | Cd48 | Cd48 molecule |
|
multiple interactions | ISO | 13 | 87,684,545 | 87,708,091 | RGD:6480464 | CTD | |
| G | Cdc23 | cell division cycle 23 |
|
decreases expression | ISO | 18 | 27,108,516 | 27,128,285 | RGD:6480464 | CTD | |
| G | Cdc42ep3 | CDC42 effector protein (Rho GTPase binding) 3 |
|
decreases expression | ISO | 6 | 2,111,458 | 2,132,242 | RGD:6480464 | CTD | |
| G | Cdc42se2 | CDC42 small effector 2 |
|
multiple interactions | ISO | 10 | 40,116,093 | 40,184,995 | RGD:6480464 | CTD | |
| G | Cdc42se2 | CDC42 small effector 2 |
|
affects expression | ISO | 10 | 40,116,093 | 40,184,995 | RGD:6480464 | CTD | |
| G | Cdc6 | cell division cycle 6 |
|
increases expression | ISO | 10 | 87,684,493 | 87,697,865 | RGD:6480464 | CTD | |
| G | Cdc6 | cell division cycle 6 |
|
multiple interactions | ISO | 10 | 87,684,493 | 87,697,865 | RGD:6480464 | CTD | |
| G | Cdc6 | cell division cycle 6 |
|
decreases expression | ISO | 10 | 87,684,493 | 87,697,865 | RGD:6480464 | CTD | |
| G | Cdc7 | cell division cycle 7 |
|
decreases expression | ISO | 14 | 3,421,621 | 3,441,738 | RGD:6480464 | CTD | |
| G | Cdc7 | cell division cycle 7 |
|
multiple interactions | ISO | 14 | 3,421,621 | 3,441,738 | RGD:6480464 | CTD | |
| G | Cdca2 | cell division cycle associated 2 |
|
increases expression | ISO | 15 | 47,225,711 | 47,271,412 | RGD:6480464 | CTD | |
| G | Cdca4 | cell division cycle associated 4 |
|
multiple interactions | ISO | 6 | 137,818,816 | 137,828,119 | RGD:6480464 | CTD | |
| G | Cdca5 | cell division cycle associated 5 |
|
multiple interactions | ISO | 1 | 210,247,351 | 210,247,881 | RGD:6480464 | CTD | |
| G | Cdca5 | cell division cycle associated 5 |
|
increases expression | ISO | 1 | 210,247,351 | 210,247,881 | RGD:6480464 | CTD | |
| G | Cdca5 | cell division cycle associated 5 |
|
multiple interactions | ISO | 1 | 210,247,351 | 210,247,881 | RGD:6480464 | CTD | |
| G | Cdca5 | cell division cycle associated 5 |
|
increases expression | ISO | 1 | 210,247,351 | 210,247,881 | RGD:6480464 | CTD | |
| G | Cdca7 | cell division cycle associated 7 |
|
decreases expression | ISO | 3 | 54,948,493 | 54,959,128 | RGD:6480464 | CTD | |
| G | Cdca8 | cell division cycle associated 8 |
|
multiple interactions | ISO | 5 | 144,251,164 | 144,276,352 | RGD:6480464 | CTD | |
| G | Cdh1 | cadherin 1 |
|
decreases expression | ISO | 19 | 36,442,693 | 36,512,091 | RGD:6480464 | CTD | |
| G | Cdh1 | cadherin 1 |
|
decreases expression | ISO | 19 | 36,442,693 | 36,512,091 | RGD:6480464 | CTD | |
| G | Cdh1 | cadherin 1 |
|
increases expression | ISO | 19 | 36,442,693 | 36,512,091 | RGD:6480464 | CTD | |
| G | Cdh1 | cadherin 1 |
|
decreases expression | ISO | 19 | 36,442,693 | 36,512,091 | RGD:6480464 | CTD | |
| G | Cdh1 | cadherin 1 |
|
multiple interactions | EXP | 19 | 36,442,693 | 36,512,091 | RGD:6480464 | CTD | |
| G | Cdh11 | cadherin 11 |
|
multiple interactions | ISO | 19 | 2,225,209 | 2,382,805 | RGD:6480464 | CTD | |
| G | Cdh11 | cadherin 11 |
|
decreases expression | ISO | 19 | 2,225,209 | 2,382,805 | RGD:6480464 | CTD | |
| G | Cdh12 | cadherin 12 |
|
increases expression | ISO | 2 | 72,175,690 | 72,598,944 | RGD:6480464 | CTD | |
| G | Cdh13 | cadherin 13 |
|
multiple interactions | ISO | 19 | 48,507,173 | 49,575,123 | RGD:6480464 | CTD | |
| G | Cdh13 | cadherin 13 |
|
multiple interactions | ISO | 19 | 48,507,173 | 49,575,123 | RGD:6480464 | CTD | |
| G | Cdh13 | cadherin 13 |
|
decreases expression | ISO | 19 | 48,507,173 | 49,575,123 | RGD:6480464 | CTD | |
| G | Cdh13 | cadherin 13 |
|
multiple interactions | EXP | 19 | 48,507,173 | 49,575,123 | RGD:6480464 | CTD | |
| G | Cdh13 | cadherin 13 |
|
decreases expression | EXP | 19 | 48,507,173 | 49,575,123 | RGD:6480464 | CTD | |
| G | Cdh16 | cadherin 16 |
|
multiple interactions | ISO | 19 | 279,359 | 289,543 | RGD:6480464 | CTD | |
| G | Cdh17 | cadherin 17 |
|
increases expression | ISO | 5 | 26,047,222 | 26,099,173 | RGD:6480464 | CTD | |
| G | Cdh2 | cadherin 2 |
|
multiple interactions | ISO | 18 | 8,048,920 | 8,267,974 | RGD:6480464 | CTD | |
| G | Cdh2 | cadherin 2 |
|
multiple interactions | ISO | 18 | 8,048,920 | 8,267,974 | RGD:6480464 | CTD | |
| G | Cdh2 | cadherin 2 |
|
decreases expression | EXP | 18 | 8,048,920 | 8,267,974 | RGD:6480464 | CTD | |
| G | Cdh23 | cadherin-related 23 |
|
multiple interactions | ISO | 20 | 27,622,049 | 28,016,145 | RGD:6480464 | CTD | |
| G | Cdh26 | cadherin 26 |
|
increases expression | ISO | 3 | 167,524,338 | 167,589,555 | RGD:6480464 | CTD | |
| G | Cdhr1 | cadherin-related family member 1 |
|
multiple interactions | ISO | 16 | 13,284,018 | 13,303,854 | RGD:6480464 | CTD | |
| G | Cdipt | CDP-diacylglycerol--inositol 3-phosphatidyltransferase |
|
multiple interactions | ISO | 1 | 186,153,278 | 186,157,415 | RGD:6480464 | CTD | |
| G | Cdipt | CDP-diacylglycerol--inositol 3-phosphatidyltransferase |
|
increases expression | ISO | 1 | 186,153,278 | 186,157,415 | RGD:6480464 | CTD | |
| G | Cdk1 | cyclin-dependent kinase 1 |
|
decreases expression | ISO | 20 | 20,018,044 | 20,044,030 | RGD:6480464 | CTD | |
| G | Cdk1 | cyclin-dependent kinase 1 |
|
multiple interactions | ISO | 20 | 20,018,044 | 20,044,030 | RGD:6480464 | CTD | |
| G | Cdk1 | cyclin-dependent kinase 1 |
|
increases expression | ISO | 20 | 20,018,044 | 20,044,030 | RGD:6480464 | CTD | |
| G | Cdk12 | cyclin-dependent kinase 12 |
|
multiple interactions | ISO | 10 | 86,972,428 | 87,027,794 | RGD:6480464 | CTD | |
| G | Cdk14 | cyclin-dependent kinase 14 |
|
multiple interactions | ISO | 4 | 25,352,280 | 25,942,686 | RGD:6480464 | CTD | |
| G | Cdk17 | cyclin-dependent kinase 17 |
|
decreases expression | ISO | 7 | 30,194,242 | 30,272,352 | RGD:6480464 | CTD | |
| G | Cdk18 | cyclin-dependent kinase 18 |
|
multiple interactions | ISO | 13 | 44,996,447 | 45,004,813 | RGD:6480464 | CTD | |
| G | Cdk18 | cyclin-dependent kinase 18 |
|
increases expression | ISO | 13 | 44,996,447 | 45,004,813 | RGD:6480464 | CTD | |
| G | Cdk19 | cyclin-dependent kinase 19 |
|
multiple interactions | ISO | 20 | 44,527,463 | 44,670,028 | RGD:6480464 | CTD | |
| G | Cdk19 | cyclin-dependent kinase 19 |
|
increases expression | ISO | 20 | 44,527,463 | 44,670,028 | RGD:6480464 | CTD | |
| G | Cdk2 | cyclin dependent kinase 2 |
|
multiple interactions | ISO | 7 | 2,000,196 | 2,007,682 | RGD:6480464 | CTD | |
| G | Cdk2 | cyclin dependent kinase 2 |
|
decreases activity | ISO | 7 | 2,000,196 | 2,007,682 | RGD:6480464 | CTD | |
| G | Cdk20 | cyclin-dependent kinase 20 |
|
multiple interactions | ISO | 17 | 6,221,255 | 6,227,959 | RGD:6480464 | CTD | |
| G | Cdk2ap2 | cyclin-dependent kinase 2 associated protein 2 |
|
increases expression | ISO | 1 | 206,681,430 | 206,683,098 | RGD:6480464 | CTD | |
| G | Cdk4 | cyclin-dependent kinase 4 | increases expression | EXP | RGD:6480464 | CTD | |||||
| G | Cdk5rap2 | CDK5 regulatory subunit associated protein 2 |
|
increases expression | ISO | 5 | 87,564,010 | 87,738,257 | RGD:6480464 | CTD | |
| G | Cebpa | CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions | ISO | 1 | 87,626,111 | 87,627,499 | RGD:6480464 | CTD | |
| G | Cebpa | CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression | ISO | 1 | 87,626,111 | 87,627,499 | RGD:6480464 | CTD | |
| G | Cebpa | CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression | ISO | 1 | 87,626,111 | 87,627,499 | RGD:6480464 | CTD | |
| G | Cebpa | CCAAT/enhancer binding protein (C/EBP), alpha |
|
increases expression | ISO | 1 | 87,626,111 | 87,627,499 | RGD:6480464 | CTD | |
| G | Cebpa | CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions | EXP | 1 | 87,626,111 | 87,627,499 | RGD:6480464 | CTD | |
| G | Cebpa | CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression | EXP | 1 | 87,626,111 | 87,627,499 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
increases activity | ISO | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions | ISO | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
increases response to substance | ISO | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression | ISO | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions | ISO | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions | ISO | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions | ISO | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions | ISO | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
affects expression | ISO | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions | ISO | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
decreases expression | ISO | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
increases activity | ISO | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
decreases expression | ISO | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression | ISO | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions | ISO | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions | EXP | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cebpd | CCAAT/enhancer binding protein (C/EBP), delta | decreases expression | ISO | RGD:6480464 | CTD | |||||
| G | Cebpd | CCAAT/enhancer binding protein (C/EBP), delta | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Cebpd | CCAAT/enhancer binding protein (C/EBP), delta | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Cebpd | CCAAT/enhancer binding protein (C/EBP), delta | increases activity | ISO | RGD:6480464 | CTD | |||||
| G | Cebpd | CCAAT/enhancer binding protein (C/EBP), delta | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Cebpd | CCAAT/enhancer binding protein (C/EBP), delta | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Cebpd | CCAAT/enhancer binding protein (C/EBP), delta | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Cebpg | CCAAT/enhancer binding protein (C/EBP), gamma |
|
decreases expression | ISO | 1 | 87,552,695 | 87,559,447 | RGD:6480464 | CTD | |
| G | Cebpz | CCAAT/enhancer binding protein zeta |
|
multiple interactions | ISO | 6 | 1,698,162 | 1,715,846 | RGD:6480464 | CTD | |
| G | Cebpz | CCAAT/enhancer binding protein zeta |
|
increases expression | ISO | 6 | 1,698,162 | 1,715,846 | RGD:6480464 | CTD | |
| G | Cebpz | CCAAT/enhancer binding protein zeta |
|
decreases expression | ISO | 6 | 1,698,162 | 1,715,846 | RGD:6480464 | CTD | |
| G | Cela1 | chymotrypsin-like elastase family, member 1 |
|
decreases expression | ISO | 7 | 139,439,589 | 139,452,717 | RGD:6480464 | CTD | |
| G | Celf2 | CUGBP, Elav-like family member 2 |
|
multiple interactions | ISO | 17 | 82,708,354 | 83,025,139 | RGD:6480464 | CTD | |
| G | Celf2 | CUGBP, Elav-like family member 2 |
|
multiple interactions | ISO | 17 | 82,708,354 | 83,025,139 | RGD:6480464 | CTD | |
| G | Celf2 | CUGBP, Elav-like family member 2 |
|
decreases expression | ISO | 17 | 82,708,354 | 83,025,139 | RGD:6480464 | CTD | |
| G | Celf5 | CUGBP, Elav-like family member 5 |
|
increases expression | ISO | 7 | 9,709,875 | 9,735,811 | RGD:6480464 | CTD | |
| G | Celsr1 | cadherin, EGF LAG seven-pass G-type receptor 1 |
|
multiple interactions | ISO | 7 | 123,900,366 | 124,036,122 | RGD:6480464 | CTD | |
| G | Celsr2 | cadherin, EGF LAG seven-pass G-type receptor 2 |
|
multiple interactions | ISO | 2 | 203,960,513 | 203,983,133 | RGD:6480464 | CTD | |
| G | Celsr2 | cadherin, EGF LAG seven-pass G-type receptor 2 |
|
decreases expression | ISO | 2 | 203,960,513 | 203,983,133 | RGD:6480464 | CTD | |
| G | Celsr2 | cadherin, EGF LAG seven-pass G-type receptor 2 |
|
multiple interactions | ISO | 2 | 203,960,513 | 203,983,133 | RGD:6480464 | CTD | |
| G | Celsr3 | cadherin, EGF LAG seven-pass G-type receptor 3 |
|
multiple interactions | ISO | 8 | 113,882,883 | 113,923,950 | RGD:6480464 | CTD | |
| G | Celsr3 | cadherin, EGF LAG seven-pass G-type receptor 3 |
|
increases expression | ISO | 8 | 113,882,883 | 113,923,950 | RGD:6480464 | CTD | |
| G | Cenpa | centromere protein A |
|
multiple interactions | ISO | 6 | 25,686,603 | 25,693,840 | RGD:6480464 | CTD | |
| G | Cfhr1 | complement factor H-related 1 |
|
increases expression | ISO | 13 | 53,135,397 | 53,150,381 | RGD:6480464 | CTD | |
| G | Chd1 | chromodomain helicase DNA binding protein 1 |
|
decreases expression | ISO | 1 | 54,594,860 | 54,631,157 | RGD:6480464 | CTD | |
| G | Chdh | choline dehydrogenase |
|
affects expression | ISO | 16 | 5,349,304 | 5,380,800 | RGD:6480464 | CTD | |
| G | Chek1 | checkpoint kinase 1 |
|
multiple interactions | ISO | 8 | 37,954,322 | 37,974,748 | RGD:6480464 | CTD | |
| G | Chek1 | checkpoint kinase 1 |
|
increases expression | ISO | 8 | 37,954,322 | 37,974,748 | RGD:6480464 | CTD | |
| G | Chga | chromogranin A (parathyroid secretory protein 1) | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Chgb | chromogranin B (secretogranin 1) |
|
multiple interactions | ISO | 3 | 120,571,736 | 120,584,874 | RGD:6480464 | CTD | |
| G | Chi3l1 | chitinase 3-like 1 (cartilage glycoprotein-39) |
|
increases expression | ISO | 13 | 47,139,658 | 47,147,591 | RGD:6480464 | CTD | |
| G | Chi3l1 | chitinase 3-like 1 (cartilage glycoprotein-39) |
|
increases expression | ISO | 13 | 47,139,658 | 47,147,591 | RGD:6480464 | CTD | |
| G | Chka | choline kinase alpha |
|
increases expression | EXP | 1 | 206,368,963 | 206,418,526 | RGD:6480464 | CTD | |
| G | Chml | choroideremia-like (Rab escort protein 2) |
|
decreases expression | ISO | 13 | 91,420,770 | 91,422,635 | RGD:6480464 | CTD | |
| G | Chmp3 | charged multivesicular body protein 3 |
|
multiple interactions | ISO | 4 | 104,812,177 | 104,857,896 | RGD:6480464 | CTD | |
| G | Chmp4bl1 | chromatin modifying protein 4B-like 1 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Chmp7 | charged multivesicular body protein 7 |
|
decreases expression | ISO | 15 | 50,089,037 | 50,104,270 | RGD:6480464 | CTD | |
| G | Chn1 | chimerin (chimaerin) 1 |
|
multiple interactions | ISO | 3 | 56,144,053 | 56,186,665 | RGD:6480464 | CTD | |
| G | Chn2 | chimerin (chimaerin) 2 |
|
decreases expression | ISO | 4 | 82,649,232 | 82,678,513 | RGD:6480464 | CTD | |
| G | Chpf2 | chondroitin polymerizing factor 2 |
|
increases expression | ISO | 4 | 5,959,923 | 5,965,385 | RGD:6480464 | CTD | |
| G | Chrdl1 | chordin-like 1 |
|
multiple interactions | ISO | X | 35,143,324 | 35,246,363 | RGD:6480464 | CTD | |
| G | Chrna3 | cholinergic receptor, nicotinic, alpha 3 (neuronal) |
|
increases expression | ISO | 8 | 58,570,223 | 58,583,594 | RGD:6480464 | CTD | |
| G | Chrne | cholinergic receptor, nicotinic, epsilon (muscle) |
|
multiple interactions | ISO | 10 | 57,497,192 | 57,501,511 | RGD:6480464 | CTD | |
| G | Chst1 | carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
|
multiple interactions | ISO | 3 | 76,994,089 | 77,008,874 | RGD:6480464 | CTD | |
| G | Chst1 | carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
|
decreases expression | ISO | 3 | 76,994,089 | 77,008,874 | RGD:6480464 | CTD | |
| G | Chst10 | carbohydrate sulfotransferase 10 |
|
multiple interactions | ISO | 9 | 37,851,796 | 37,881,657 | RGD:6480464 | CTD | |
| G | Chst11 | carbohydrate (chondroitin 4) sulfotransferase 11 |
|
decreases expression | ISO | 7 | 22,721,892 | 22,950,084 | RGD:6480464 | CTD | |
| G | Chst11 | carbohydrate (chondroitin 4) sulfotransferase 11 |
|
increases expression | ISO | 7 | 22,721,892 | 22,950,084 | RGD:6480464 | CTD | |
| G | Chst2 | carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2 |
|
multiple interactions | ISO | 8 | 100,497,213 | 100,498,704 | RGD:6480464 | CTD | |
| G | Chst2 | carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2 |
|
increases expression | ISO | 8 | 100,497,213 | 100,498,704 | RGD:6480464 | CTD | |
| G | Chst9 | carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 9 |
|
increases expression | ISO | 18 | 6,698,623 | 6,959,482 | RGD:6480464 | CTD | |
| G | Chsy1 | chondroitin sulfate synthase 1 |
|
affects expression | ISO | 1 | 120,539,002 | 120,600,102 | RGD:6480464 | CTD | |
| G | Chtf18 | CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae) |
|
increases expression | ISO | 10 | 14,988,146 | 14,996,182 | RGD:6480464 | CTD | |
| G | Chtf18 | CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae) |
|
multiple interactions | ISO | 10 | 14,988,146 | 14,996,182 | RGD:6480464 | CTD | |
| G | Chuk | conserved helix-loop-helix ubiquitous kinase |
|
multiple interactions | ISO | 1 | 249,122,845 | 249,158,369 | RGD:6480464 | CTD | |
| G | Ciao1 | cytosolic iron-sulfur protein assembly 1 |
|
multiple interactions | ISO | 3 | 114,740,676 | 114,746,203 | RGD:6480464 | CTD | |
| G | Cib1 | calcium and integrin binding 1 (calmyrin) |
|
increases expression | ISO | 1 | 136,031,865 | 136,045,153 | RGD:6480464 | CTD | |
| G | Cib1 | calcium and integrin binding 1 (calmyrin) |
|
multiple interactions | ISO | 1 | 136,031,865 | 136,045,153 | RGD:6480464 | CTD | |
| G | Cidea | cell death-inducing DFFA-like effector a |
|
multiple interactions | ISO | 18 | 63,871,538 | 63,896,975 | RGD:6480464 | CTD | |
| G | Cideb | cell death-inducing DFFA-like effector b |
|
increases expression | ISO | 15 | 33,916,472 | 33,920,872 | RGD:6480464 | CTD | |
| G | Cideb | cell death-inducing DFFA-like effector b |
|
increases expression | ISO | 15 | 33,916,472 | 33,920,872 | RGD:6480464 | CTD | |
| G | Cidec | cell death-inducing DFFA-like effector c |
|
decreases expression | ISO | 4 | 149,307,986 | 149,321,303 | RGD:6480464 | CTD | |
| G | Cidec | cell death-inducing DFFA-like effector c |
|
increases expression | ISO | 4 | 149,307,986 | 149,321,303 | RGD:6480464 | CTD | |
| G | Cirbp | cold inducible RNA binding protein |
|
multiple interactions | ISO | 7 | 11,047,003 | 11,050,820 | RGD:6480464 | CTD | |
| G | Cirbp | cold inducible RNA binding protein |
|
decreases expression | ISO | 7 | 11,047,003 | 11,050,820 | RGD:6480464 | CTD | |
| G | Cisd2 | CDGSH iron sulfur domain 2 |
|
increases expression | ISO | 2 | 232,902,533 | 232,927,338 | RGD:6480464 | CTD | |
| G | Cish | cytokine inducible SH2-containing protein |
|
multiple interactions | ISO | 8 | 112,541,034 | 112,545,982 | RGD:6480464 | CTD | |
| G | Cish | cytokine inducible SH2-containing protein |
|
increases expression | ISO | 8 | 112,541,034 | 112,545,982 | RGD:6480464 | CTD | |
| G | Cited2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
multiple interactions | ISO | 1 | 12,721,500 | 12,723,943 | RGD:6480464 | CTD | |
| G | Cited2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
multiple interactions | ISO | 1 | 12,721,500 | 12,723,943 | RGD:6480464 | CTD | |
| G | Cited2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
decreases expression | ISO | 1 | 12,721,500 | 12,723,943 | RGD:6480464 | CTD | |
| G | Cited2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
multiple interactions | ISO | 1 | 12,721,500 | 12,723,943 | RGD:6480464 | CTD | |
| G | Cited2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
multiple interactions | ISO | 1 | 12,721,500 | 12,723,943 | RGD:6480464 | CTD | |
| G | Cited2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
decreases expression | ISO | 1 | 12,721,500 | 12,723,943 | RGD:6480464 | CTD | |
| G | Cited2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
decreases expression | EXP | 1 | 12,721,500 | 12,723,943 | RGD:6480464 | CTD | |
| G | Cited4 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
|
multiple interactions | ISO | 5 | 141,258,564 | 141,259,455 | RGD:6480464 | CTD | |
| G | Ckb | creatine kinase, brain |
|
increases expression | EXP | 6 | 136,452,215 | 136,455,122 | RGD:6480464 | CTD | |
| G | Ckm | creatine kinase, muscle |
|
multiple interactions | ISO | 1 | 78,762,202 | 78,772,681 | RGD:6480464 | CTD | |
| G | Ckmt2 | creatine kinase, mitochondrial 2, sarcomeric |
|
multiple interactions | ISO | 2 | 22,084,948 | 22,106,014 | RGD:6480464 | CTD | |
| G | Clic3 | chloride intracellular channel 3 |
|
increases expression | ISO | 3 | 3,622,894 | 3,624,805 | RGD:6480464 | CTD | |
| G | Clic3 | chloride intracellular channel 3 |
|
increases expression | ISO | 3 | 3,622,894 | 3,624,805 | RGD:6480464 | CTD | |
| G | Clu | clusterin |
|
decreases expression | ISO | 15 | 45,365,779 | 45,405,314 | RGD:6480464 | CTD | |
| G | Clu | clusterin |
|
increases expression | ISO | 15 | 45,365,779 | 45,405,314 | RGD:6480464 | CTD | |
| G | Cma1 | chymase 1, mast cell |
|
decreases expression | ISO | 15 | 34,083,202 | 34,084,387 | RGD:6480464 | CTD | |
| G | Cmas | cytidine monophosphate N-acetylneuraminic acid synthetase |
|
multiple interactions | ISO | 4 | 180,650,927 | 180,669,243 | RGD:6480464 | CTD | |
| G | Cmbl | carboxymethylenebutenolidase homolog (Pseudomonas) |
|
decreases expression | EXP | 2 | 83,659,292 | 83,681,042 | RGD:6480464 | CTD | |
| G | Cml1 | camello-like 1 |
|
multiple interactions | ISO | 4 | 120,059,311 | 120,065,996 | RGD:6480464 | CTD | |
| G | Cml1 | camello-like 1 |
|
decreases expression | ISO | 4 | 120,059,311 | 120,065,996 | RGD:6480464 | CTD | |
| G | Cml1 | camello-like 1 |
|
multiple interactions | ISO | 4 | 120,059,311 | 120,065,996 | RGD:6480464 | CTD | |
| G | Cml5 | camello-like 5 |
|
multiple interactions | ISO | 4 | 119,981,266 | 120,006,794 | RGD:6480464 | CTD | |
| G | Cml5 | camello-like 5 |
|
increases expression | ISO | 4 | 119,981,266 | 120,006,794 | RGD:6480464 | CTD | |
| G | Cmpk1 | cytidine monophosphate (UMP-CMP) kinase 1 |
|
decreases expression | ISO | 5 | 135,320,845 | 135,348,973 | RGD:6480464 | CTD | |
| G | Cmtm3 | CKLF-like MARVEL transmembrane domain containing 3 |
|
increases expression | ISO | 19 | 579,430 | 586,297 | RGD:6480464 | CTD | |
| G | Cmtm7 | CKLF-like MARVEL transmembrane domain containing 7 |
|
multiple interactions | ISO | 8 | 119,175,165 | 119,202,081 | RGD:6480464 | CTD | |
| G | Cmtm7 | CKLF-like MARVEL transmembrane domain containing 7 |
|
increases expression | ISO | 8 | 119,175,165 | 119,202,081 | RGD:6480464 | CTD | |
| G | Cmtm8 | CKLF-like MARVEL transmembrane domain containing 8 |
|
multiple interactions | ISO | 8 | 119,209,101 | 119,265,441 | RGD:6480464 | CTD | |
| G | Cmtm8 | CKLF-like MARVEL transmembrane domain containing 8 |
|
decreases expression | ISO | 8 | 119,209,101 | 119,265,441 | RGD:6480464 | CTD | |
| G | Cndp2 | CNDP dipeptidase 2 (metallopeptidase M20 family) |
|
increases expression | ISO | 18 | 81,215,851 | 81,232,949 | RGD:6480464 | CTD | |
| G | Cnga2 | cyclic nucleotide gated channel alpha 2 |
|
multiple interactions | ISO | X | 157,558,962 | 157,575,781 | RGD:6480464 | CTD | |
| G | Cnga2 | cyclic nucleotide gated channel alpha 2 |
|
multiple interactions | ISO | X | 157,558,962 | 157,575,781 | RGD:6480464 | CTD | |
| G | Cnih | cornichon homolog (Drosophila) |
|
multiple interactions | ISO | 15 | 22,632,778 | 22,644,552 | RGD:6480464 | CTD | |
| G | Cnih | cornichon homolog (Drosophila) |
|
increases expression | ISO | 15 | 22,632,778 | 22,644,552 | RGD:6480464 | CTD | |
| G | Cnih | cornichon homolog (Drosophila) |
|
decreases expression | ISO | 15 | 22,632,778 | 22,644,552 | RGD:6480464 | CTD | |
| G | Cnih2 | cornichon homolog 2 (Drosophila) |
|
multiple interactions | ISO | 1 | 207,715,692 | 207,717,588 | RGD:6480464 | CTD | |
| G | Cnih2 | cornichon homolog 2 (Drosophila) |
|
increases expression | ISO | 1 | 207,715,692 | 207,717,588 | RGD:6480464 | CTD | |
| G | Cnn1 | calponin 1, basic, smooth muscle |
|
increases expression | ISO | 8 | 21,210,524 | 21,221,024 | RGD:6480464 | CTD | |
| G | Cnn1 | calponin 1, basic, smooth muscle |
|
multiple interactions | ISO | 8 | 21,210,524 | 21,221,024 | RGD:6480464 | CTD | |
| G | Cnn3 | calponin 3, acidic |
|
increases expression | EXP | 2 | 218,044,803 | 218,075,914 | RGD:6480464 | CTD | |
| G | Cnnm2 | cyclin M2 |
|
multiple interactions | ISO | 1 | 252,077,259 | 252,195,971 | RGD:6480464 | CTD | |
| G | Cnot1 | CCR4-NOT transcription complex, subunit 1 |
|
increases expression | ISO | 19 | 9,712,024 | 9,803,182 | RGD:6480464 | CTD | |
| G | Cnot4 | CCR4-NOT transcription complex, subunit 4 |
|
multiple interactions | ISO | 4 | 62,437,688 | 62,548,524 | RGD:6480464 | CTD | |
| G | Cnot4 | CCR4-NOT transcription complex, subunit 4 |
|
increases expression | ISO | 4 | 62,437,688 | 62,548,524 | RGD:6480464 | CTD | |
| G | Cnpy2 | canopy 2 homolog (zebrafish) |
|
multiple interactions | ISO | 7 | 1,611,268 | 1,615,873 | RGD:6480464 | CTD | |
| G | Cnpy2 | canopy 2 homolog (zebrafish) |
|
increases expression | ISO | 7 | 1,611,268 | 1,615,873 | RGD:6480464 | CTD | |
| G | Cnr2 | cannabinoid receptor 2 (macrophage) |
|
multiple interactions | ISO | 5 | 154,674,754 | 154,702,552 | RGD:6480464 | CTD | |
| G | Cntnap2 | contactin associated protein-like 2 |
|
multiple interactions | ISO | 4 | 74,277,978 | 75,440,178 | RGD:6480464 | CTD | |
| G | Cobl | cordon-bleu WH2 repeat protein |
|
decreases expression | ISO | 14 | 93,154,637 | 93,309,406 | RGD:6480464 | CTD | |
| G | Cobll1 | cordon-bleu WH2 repeat protein-like 1 |
|
decreases expression | ISO | 3 | 47,024,613 | 47,035,010 | RGD:6480464 | CTD | |
| G | Cog6 | component of oligomeric golgi complex 6 |
|
decreases expression | ISO | 2 | 142,767,258 | 142,804,731 | RGD:6480464 | CTD | |
| G | Cog8 | component of oligomeric golgi complex 8 |
|
multiple interactions | ISO | 19 | 36,904,222 | 36,914,972 | RGD:6480464 | CTD | |
| G | Col11a1 | collagen, type XI, alpha 1 |
|
affects expression | ISO | 2 | 209,996,467 | 210,193,379 | RGD:6480464 | CTD | |
| G | Col11a1 | collagen, type XI, alpha 1 |
|
increases expression | EXP | 2 | 209,996,467 | 210,193,379 | RGD:6480464 | CTD | |
| G | Col11a1 | collagen, type XI, alpha 1 |
|
multiple interactions | ISO | 2 | 209,996,467 | 210,193,379 | RGD:6480464 | CTD | |
| G | Col12a1 | collagen, type XII, alpha 1 |
|
affects expression | ISO | 8 | 84,641,358 | 84,756,923 | RGD:6480464 | CTD | |
| G | Col13a1 | collagen, type XIII, alpha 1 |
|
increases expression | ISO | 20 | 29,208,654 | 29,348,751 | RGD:6480464 | CTD | |
| G | Col13a1 | collagen, type XIII, alpha 1 |
|
multiple interactions | ISO | 20 | 29,208,654 | 29,348,751 | RGD:6480464 | CTD | |
| G | Col13a1 | collagen, type XIII, alpha 1 |
|
increases expression | ISO | 20 | 29,208,654 | 29,348,751 | RGD:6480464 | CTD | |
| G | Col14a1 | collagen, type XIV, alpha 1 |
|
affects expression | ISO | 7 | 91,801,534 | 92,032,966 | RGD:6480464 | CTD | |
| G | Col15a1 | collagen, type XV, alpha 1 |
|
affects expression | ISO | 5 | 63,825,907 | 63,930,633 | RGD:6480464 | CTD | |
| G | Col15a1 | collagen, type XV, alpha 1 |
|
multiple interactions | ISO | 5 | 63,825,907 | 63,930,633 | RGD:6480464 | CTD | |
| G | Col15a1 | collagen, type XV, alpha 1 |
|
multiple interactions | ISO | 5 | 63,825,907 | 63,930,633 | RGD:6480464 | CTD | |
| G | Col18a1 | collagen, type XVIII, alpha 1 |
|
multiple interactions | ISO | 20 | 11,920,816 | 11,982,468 | RGD:6480464 | CTD | |
| G | Col18a1 | collagen, type XVIII, alpha 1 |
|
decreases expression | EXP | 20 | 11,920,816 | 11,982,468 | RGD:6480464 | CTD | |
| G | Col18a1 | collagen, type XVIII, alpha 1 |
|
decreases expression | ISO | 20 | 11,920,816 | 11,982,468 | RGD:6480464 | CTD | |
| G | Col19a1 | collagen, type XIX, alpha 1 |
|
multiple interactions | ISO | 9 | 23,003,618 | 23,337,800 | RGD:6480464 | CTD | |
| G | Col6a3 | collagen, type VI, alpha 3 |
|
multiple interactions | ISO | 9 | 89,990,129 | 90,043,697 | RGD:6480464 | CTD | |
| G | Col6a3 | collagen, type VI, alpha 3 |
|
multiple interactions | ISO | 9 | 89,990,129 | 90,043,697 | RGD:6480464 | CTD | |
| G | Col6a3 | collagen, type VI, alpha 3 |
|
multiple interactions | ISO | 9 | 89,990,129 | 90,043,697 | RGD:6480464 | CTD | |
| G | Col6a3 | collagen, type VI, alpha 3 |
|
increases expression | ISO | 9 | 89,990,129 | 90,043,697 | RGD:6480464 | CTD | |
| G | Commd1 | copper metabolism (Murr1) domain containing 1 |
|
multiple interactions | ISO | 14 | 103,571,472 | 103,667,692 | RGD:6480464 | CTD | |
| G | Copz2 | coatomer protein complex, subunit zeta 2 |
|
multiple interactions | ISO | 10 | 85,607,750 | 85,622,492 | RGD:6480464 | CTD | |
| G | Coq6 | coenzyme Q6 homolog, monooxygenase (S. cerevisiae) |
|
affects expression | ISO | 6 | 108,425,610 | 108,436,950 | RGD:6480464 | CTD | |
| G | Coq6 | coenzyme Q6 homolog, monooxygenase (S. cerevisiae) |
|
increases expression | EXP | 6 | 108,425,610 | 108,436,950 | RGD:6480464 | CTD | |
| G | Coq7 | coenzyme Q7 homolog, ubiquinone (yeast) |
|
multiple interactions | ISO | 1 | 176,722,271 | 176,746,436 | RGD:6480464 | CTD | |
| G | Coro1b | coronin, actin-binding protein, 1B |
|
multiple interactions | ISO | 1 | 206,733,360 | 206,738,018 | RGD:6480464 | CTD | |
| G | Coro1b | coronin, actin-binding protein, 1B |
|
increases expression | ISO | 1 | 206,733,360 | 206,738,018 | RGD:6480464 | CTD | |
| G | Coro2b | coronin, actin binding protein, 2B |
|
multiple interactions | ISO | 8 | 66,573,135 | 66,651,600 | RGD:6480464 | CTD | |
| G | Coro7 | coronin 7 |
|
affects expression | ISO | 10 | 11,014,535 | 11,070,332 | RGD:6480464 | CTD | |
| G | Coro7 | coronin 7 |
|
multiple interactions | ISO | 10 | 11,014,535 | 11,070,332 | RGD:6480464 | CTD | |
| G | Cort | cortistatin |
|
multiple interactions | ISO | 5 | 166,198,987 | 166,200,428 | RGD:6480464 | CTD | |
| G | Cotl1 | coactosin-like 1 (Dictyostelium) |
|
decreases expression | ISO | 19 | 50,096,620 | 50,130,253 | RGD:6480464 | CTD | |
| G | Cotl1 | coactosin-like 1 (Dictyostelium) |
|
decreases expression | ISO | 19 | 50,096,620 | 50,130,253 | RGD:6480464 | CTD | |
| G | Cotl1 | coactosin-like 1 (Dictyostelium) |
|
affects expression | ISO | 19 | 50,096,620 | 50,130,253 | RGD:6480464 | CTD | |
| G | Cox19 | cytochrome c oxidase assembly homolog 19 (S. cerevisiae) |
|
multiple interactions | ISO | 12 | 15,804,279 | 15,812,139 | RGD:6480464 | CTD | |
| G | Cox19 | cytochrome c oxidase assembly homolog 19 (S. cerevisiae) |
|
increases expression | ISO | 12 | 15,804,279 | 15,812,139 | RGD:6480464 | CTD | |
| G | Cox4i1 | cytochrome c oxidase subunit IV isoform 1 |
|
increases expression | ISO | 19 | 51,023,960 | 51,030,200 | RGD:6480464 | CTD | |
| G | Cox4i2 | cytochrome c oxidase subunit IV isoform 2 (lung) |
|
increases expression | ISO | 3 | 143,103,348 | 143,114,236 | RGD:6480464 | CTD | |
| G | Cox4nb | COX4 neighbor |
|
affects expression | ISO | 19 | 51,013,951 | 51,023,812 | RGD:6480464 | CTD | |
| G | Cox4nb | COX4 neighbor |
|
multiple interactions | ISO | 19 | 51,013,951 | 51,023,812 | RGD:6480464 | CTD | |
| G | Cox4nb | COX4 neighbor |
|
increases expression | ISO | 19 | 51,013,951 | 51,023,812 | RGD:6480464 | CTD | |
| G | Cox5a | cytochrome c oxidase, subunit Va |
|
multiple interactions | ISO | 8 | 61,264,971 | 61,276,380 | RGD:6480464 | CTD | |
| G | Cox5a | cytochrome c oxidase, subunit Va |
|
increases expression | EXP | 8 | 61,264,971 | 61,276,380 | RGD:6480464 | CTD | |
| G | Cox5b | cytochrome c oxidase subunit Vb |
|
increases expression | ISO | 9 | 35,625,478 | 35,627,304 | RGD:6480464 | CTD | |
| G | Cox5b | cytochrome c oxidase subunit Vb |
|
multiple interactions | ISO | 9 | 35,625,478 | 35,627,304 | RGD:6480464 | CTD | |
| G | Cox6a1 | cytochrome c oxidase, subunit VIa, polypeptide 1 |
|
increases expression | ISO | 12 | 42,530,091 | 42,533,144 | RGD:6480464 | CTD | |
| G | Cox6a2 | cytochrome c oxidase subunit VIa polypeptide 2 |
|
decreases expression | ISO | 1 | 187,464,579 | 187,465,301 | RGD:6480464 | CTD | |
| G | Cox6b1 | cytochrome c oxidase subunit VIb polypeptide 1 |
|
increases expression | ISO | 1 | 85,669,891 | 85,677,195 | RGD:6480464 | CTD | |
| G | Cox6b2 | cytochrome c oxidase subunit VIb polypeptide 2 |
|
decreases expression | ISO | 1 | 67,810,527 | 67,811,752 | RGD:6480464 | CTD | |
| G | Cox6c | cytochrome c oxidase, subunit VIc |
|
multiple interactions | ISO | 7 | 71,465,790 | 71,478,524 | RGD:6480464 | CTD | |
| G | Cox6c | cytochrome c oxidase, subunit VIc |
|
increases expression | ISO | 7 | 71,465,790 | 71,478,524 | RGD:6480464 | CTD | |
| G | Cox7a2 | cytochrome c oxidase subunit VIIa polypeptide 2 |
|
increases expression | ISO | 8 | 84,813,292 | 84,817,390 | RGD:6480464 | CTD | |
| G | Cox7a2l | cytochrome c oxidase subunit VIIa polypeptide 2 like |
|
multiple interactions | ISO | 6 | 6,834,523 | 6,861,652 | RGD:6480464 | CTD | |
| G | Cox7b | cytochrome c oxidase subunit VIIb |
|
increases expression | ISO | X | 94,138,056 | 94,144,305 | RGD:6480464 | CTD | |
| G | Cox7c | cytochrome c oxidase, subunit VIIc |
|
multiple interactions | ISO | 2 | 15,254,040 | 15,256,065 | RGD:6480464 | CTD | |
| G | Cp | ceruloplasmin (ferroxidase) |
|
multiple interactions | ISO | 2 | 105,086,278 | 105,135,367 | RGD:6480464 | CTD | |
| G | Cp | ceruloplasmin (ferroxidase) |
|
decreases expression | ISO | 2 | 105,086,278 | 105,135,367 | RGD:6480464 | CTD | |
| G | Cp | ceruloplasmin (ferroxidase) |
|
multiple interactions | ISO | 2 | 105,086,278 | 105,135,367 | RGD:6480464 | CTD | |
| G | Cp | ceruloplasmin (ferroxidase) |
|
multiple interactions | ISO | 2 | 105,086,278 | 105,135,367 | RGD:6480464 | CTD | |
| G | Cp | ceruloplasmin (ferroxidase) |
|
increases expression | ISO | 2 | 105,086,278 | 105,135,367 | RGD:6480464 | CTD | |
| G | Cp | ceruloplasmin (ferroxidase) |
|
decreases expression | ISO | 2 | 105,086,278 | 105,135,367 | RGD:6480464 | CTD | |
| G | Cpa3 | carboxypeptidase A3, mast cell |
|
multiple interactions | ISO | 2 | 105,368,835 | 105,402,657 | RGD:6480464 | CTD | |
| G | Cpa3 | carboxypeptidase A3, mast cell |
|
decreases expression | ISO | 2 | 105,368,835 | 105,402,657 | RGD:6480464 | CTD | |
| G | Cpa5 | carboxypeptidase A5 |
|
multiple interactions | ISO | 4 | 57,522,649 | 57,541,340 | RGD:6480464 | CTD | |
| G | Cpb1 | carboxypeptidase B1 (tissue) |
|
multiple interactions | ISO | 2 | 105,413,336 | 105,443,909 | RGD:6480464 | CTD | |
| G | Cpb2 | carboxypeptidase B2 (plasma) |
|
increases expression | EXP | 15 | 56,104,920 | 56,154,321 | RGD:6480464 | CTD | |
| G | Cpb2 | carboxypeptidase B2 (plasma) |
|
decreases expression | ISO | 15 | 56,104,920 | 56,154,321 | RGD:6480464 | CTD | |
| G | Cpd | carboxypeptidase D |
|
multiple interactions | ISO | 10 | 67,327,272 | 67,390,836 | RGD:6480464 | CTD | |
| G | Cpd | carboxypeptidase D |
|
decreases expression | EXP | 10 | 67,327,272 | 67,390,836 | RGD:6480464 | CTD | |
| G | Cpe | carboxypeptidase E | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Cpe | carboxypeptidase E | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Cpe | carboxypeptidase E | decreases expression | ISO | RGD:6480464 | CTD | |||||
| G | Cped1 | cadherin-like and PC-esterase domain containing 1 |
|
decreases expression | ISO | 4 | 48,295,056 | 48,568,314 | RGD:6480464 | CTD | |
| G | Crct1 | cysteine-rich C-terminal 1 |
|
decreases expression | ISO | 2 | 186,049,344 | 186,049,949 | RGD:6480464 | CTD | |
| G | Crp | C-reactive protein, pentraxin-related |
|
decreases expression | EXP | 13 | 88,702,243 | 88,703,153 | RGD:6480464 | CTD | |
| G | Cry1 | cryptochrome 1 (photolyase-like) |
|
decreases expression | ISO | 7 | 20,643,879 | 20,709,216 | RGD:6480464 | CTD | |
| G | Cry1 | cryptochrome 1 (photolyase-like) |
|
multiple interactions | ISO | 7 | 20,643,879 | 20,709,216 | RGD:6480464 | CTD | |
| G | Cry1 | cryptochrome 1 (photolyase-like) |
|
increases expression | ISO | 7 | 20,643,879 | 20,709,216 | RGD:6480464 | CTD | |
| G | Cry2 | cryptochrome 2 (photolyase-like) |
|
increases expression | ISO | 3 | 76,802,782 | 76,830,902 | RGD:6480464 | CTD | |
| G | Cryaa | crystallin, alpha A | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Cryab | crystallin, alpha B |
|
multiple interactions | ISO | 8 | 54,107,824 | 54,111,502 | RGD:6480464 | CTD | |
| G | Cryba1 | crystallin, beta A1 |
|
multiple interactions | ISO | 10 | 63,758,929 | 63,765,451 | RGD:6480464 | CTD | |
| G | Cryba2 | crystallin, beta A2 |
|
multiple interactions | ISO | 9 | 74,222,839 | 74,226,049 | RGD:6480464 | CTD | |
| G | Crygb | crystallin, gamma B |
|
multiple interactions | ISO | 9 | 63,730,906 | 63,732,966 | RGD:6480464 | CTD | |
| G | Cryge | crystallin, gamma E |
|
multiple interactions | ISO | 9 | 63,698,609 | 63,701,230 | RGD:6480464 | CTD | |
| G | Crygn | crystallin, gamma N |
|
multiple interactions | ISO | 4 | 5,772,670 | 5,778,384 | RGD:6480464 | CTD | |
| G | Crygs | crystallin, gamma S |
|
multiple interactions | ISO | 11 | 80,417,632 | 80,437,802 | RGD:6480464 | CTD | |
| G | Cryl1 | crystallin, lambda 1 |
|
multiple interactions | ISO | 15 | 36,320,075 | 36,440,579 | RGD:6480464 | CTD | |
| G | Cryl1 | crystallin, lambda 1 |
|
increases expression | ISO | 15 | 36,320,075 | 36,440,579 | RGD:6480464 | CTD | |
| G | Cryl1 | crystallin, lambda 1 |
|
multiple interactions | ISO | 15 | 36,320,075 | 36,440,579 | RGD:6480464 | CTD | |
| G | Cryz | crystallin, zeta (quinone reductase) |
|
decreases expression | ISO | 2 | 252,433,559 | 252,461,038 | RGD:6480464 | CTD | |
| G | Cryz | crystallin, zeta (quinone reductase) |
|
multiple interactions | ISO | 2 | 252,433,559 | 252,461,038 | RGD:6480464 | CTD | |
| G | Cryz | crystallin, zeta (quinone reductase) |
|
increases activity | ISO | 2 | 252,433,559 | 252,461,038 | RGD:6480464 | CTD | |
| G | Cryz | crystallin, zeta (quinone reductase) |
|
increases expression | ISO | 2 | 252,433,559 | 252,461,038 | RGD:6480464 | CTD | |
| G | Cs | citrate synthase |
|
decreases expression | ISO | 7 | 1,626,181 | 1,652,197 | RGD:6480464 | CTD | |
| G | Cs | citrate synthase |
|
multiple interactions | ISO | 7 | 1,626,181 | 1,652,197 | RGD:6480464 | CTD | |
| G | Cs | citrate synthase |
|
multiple interactions | ISO | 7 | 1,626,181 | 1,652,197 | RGD:6480464 | CTD | |
| G | Csad | cysteine sulfinic acid decarboxylase |
|
multiple interactions | ISO | 7 | 140,917,995 | 140,944,405 | RGD:6480464 | CTD | |
| G | Csad | cysteine sulfinic acid decarboxylase |
|
decreases expression | ISO | 7 | 140,917,995 | 140,944,405 | RGD:6480464 | CTD | |
| G | Cse1l | CSE1 chromosome segregation 1-like (yeast) |
|
multiple interactions | ISO | 3 | 158,061,678 | 158,100,065 | RGD:6480464 | CTD | |
| G | Cse1l | CSE1 chromosome segregation 1-like (yeast) |
|
increases expression | ISO | 3 | 158,061,678 | 158,100,065 | RGD:6480464 | CTD | |
| G | Csf1 | colony stimulating factor 1 (macrophage) |
|
multiple interactions | ISO | 2 | 203,292,765 | 203,307,968 | RGD:6480464 | CTD | |
| G | Csf1 | colony stimulating factor 1 (macrophage) |
|
increases expression | ISO | 2 | 203,292,765 | 203,307,968 | RGD:6480464 | CTD | |
| G | Csf1 | colony stimulating factor 1 (macrophage) |
|
multiple interactions | ISO | 2 | 203,292,765 | 203,307,968 | RGD:6480464 | CTD | |
| G | Csf1 | colony stimulating factor 1 (macrophage) |
|
decreases expression | ISO | 2 | 203,292,765 | 203,307,968 | RGD:6480464 | CTD | |
| G | Csf1r | colony stimulating factor 1 receptor |
|
multiple interactions | ISO | 18 | 57,080,324 | 57,107,295 | RGD:6480464 | CTD | |
| G | Csf2 | colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions | ISO | 10 | 39,665,850 | 39,667,831 | RGD:6480464 | CTD | |
| G | Csf2 | colony stimulating factor 2 (granulocyte-macrophage) |
|
increases expression | ISO | 10 | 39,665,850 | 39,667,831 | RGD:6480464 | CTD | |
| G | Csf2rb | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
|
increases expression | ISO | 7 | 116,227,239 | 116,271,993 | RGD:6480464 | CTD | |
| G | Csf3 | colony stimulating factor 3 (granulocyte) |
|
increases expression | ISO | 10 | 87,473,990 | 87,476,365 | RGD:6480464 | CTD | |
| G | Csgalnact2 | chondroitin sulfate N-acetylgalactosaminyltransferase 2 |
|
decreases expression | ISO | 4 | 154,399,859 | 154,431,049 | RGD:6480464 | CTD | |
| G | Csk | c-src tyrosine kinase |
|
increases expression | EXP | 8 | 61,381,336 | 61,386,013 | RGD:6480464 | CTD | |
| G | Csn2 | casein beta |
|
decreases expression | ISO | 14 | 21,847,981 | 21,855,216 | RGD:6480464 | CTD | |
| G | Csnk1a1 | casein kinase 1, alpha 1 |
|
decreases expression | EXP | 18 | 57,541,673 | 57,564,560 | RGD:6480464 | CTD | |
| G | Csnk1d | casein kinase 1, delta |
|
multiple interactions | ISO | 10 | 110,166,244 | 110,197,233 | RGD:6480464 | CTD | |
| G | Csnk1d | casein kinase 1, delta |
|
decreases expression | ISO | 10 | 110,166,244 | 110,197,233 | RGD:6480464 | CTD | |
| G | Csnk1g1 | casein kinase 1, gamma 1 |
|
multiple interactions | ISO | 8 | 70,193,231 | 70,301,592 | RGD:6480464 | CTD | |
| G | Csnk1g1 | casein kinase 1, gamma 1 |
|
increases expression | ISO | 8 | 70,193,231 | 70,301,592 | RGD:6480464 | CTD | |
| G | Csnk1g3 | casein kinase 1, gamma 3 |
|
multiple interactions | ISO | 18 | 49,369,579 | 49,451,893 | RGD:6480464 | CTD | |
| G | Csnk2a1 | casein kinase 2, alpha 1 polypeptide |
|
affects expression | ISO | 3 | 142,564,754 | 142,609,311 | RGD:6480464 | CTD | |
| G | Ctsd | cathepsin D |
|
multiple interactions | ISO | 1 | 202,619,669 | 202,631,545 | RGD:6480464 | CTD | |
| G | Ctsd | cathepsin D |
|
multiple interactions | ISO | 1 | 202,619,669 | 202,631,545 | RGD:6480464 | CTD | |
| G | Ctsd | cathepsin D |
|
decreases expression | ISO | 1 | 202,619,669 | 202,631,545 | RGD:6480464 | CTD | |
| G | Ctsd | cathepsin D |
|
increases expression | ISO | 1 | 202,619,669 | 202,631,545 | RGD:6480464 | CTD | |
| G | Ctsg | cathepsin G |
|
increases expression | ISO | 15 | 34,622,211 | 34,624,798 | RGD:6480464 | CTD | |
| G | Ctsh | cathepsin H |
|
multiple interactions | ISO | 8 | 94,971,689 | 94,990,434 | RGD:6480464 | CTD | |
| G | Ctsl1 | cathepsin L1 |
|
multiple interactions | ISO | 17 | 6,288,013 | 6,294,174 | RGD:6480464 | CTD | |
| G | Ctsl1 | cathepsin L1 |
|
affects expression | ISO | 17 | 6,288,013 | 6,294,174 | RGD:6480464 | CTD | |
| G | Ctsl1 | cathepsin L1 |
|
multiple interactions | ISO | 17 | 6,288,013 | 6,294,174 | RGD:6480464 | CTD | |
| G | Ctsl1 | cathepsin L1 |
|
multiple interactions | ISO | 17 | 6,288,013 | 6,294,174 | RGD:6480464 | CTD | |
| G | Ctsl1 | cathepsin L1 |
|
increases expression | ISO | 17 | 6,288,013 | 6,294,174 | RGD:6480464 | CTD | |
| G | Ctsl1 | cathepsin L1 |
|
decreases expression | ISO | 17 | 6,288,013 | 6,294,174 | RGD:6480464 | CTD | |
| G | Ctsl1 | cathepsin L1 |
|
increases expression | ISO | 17 | 6,288,013 | 6,294,174 | RGD:6480464 | CTD | |
| G | Ctsl1 | cathepsin L1 |
|
increases expression | EXP | 17 | 6,288,013 | 6,294,174 | RGD:6480464 | CTD | |
| G | Ctsl1 | cathepsin L1 |
|
increases expression | EXP | 17 | 6,288,013 | 6,294,174 | RGD:6480464 | CTD | |
| G | Ctss | cathepsin S |
|
increases expression | ISO | 2 | 190,425,290 | 190,466,877 | RGD:6480464 | CTD | |
| G | Ctss | cathepsin S |
|
multiple interactions | ISO | 2 | 190,425,290 | 190,466,877 | RGD:6480464 | CTD | |
| G | Ctsw | cathepsin W |
|
multiple interactions | ISO | 1 | 208,108,632 | 208,112,020 | RGD:6480464 | CTD | |
| G | Ctsz | cathepsin Z | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Ctxn1 | cortexin 1 |
|
decreases expression | ISO | 12 | 1,531,822 | 1,533,433 | RGD:6480464 | CTD | |
| G | Ctxn1 | cortexin 1 |
|
increases expression | ISO | 12 | 1,531,822 | 1,533,433 | RGD:6480464 | CTD | |
| G | Cuedc1 | CUE domain containing 1 |
|
increases expression | ISO | 10 | 76,467,673 | 76,488,136 | RGD:6480464 | CTD | |
| G | Cul2 | cullin 2 |
|
increases expression | ISO | 17 | 62,701,289 | 62,741,344 | RGD:6480464 | CTD | |
| G | Cul3 | cullin 3 |
|
decreases expression | ISO | 9 | 79,574,062 | 79,634,396 | RGD:6480464 | CTD | |
| G | Cul4b | cullin 4B |
|
increases expression | ISO | X | 6,800,506 | 6,838,023 | RGD:6480464 | CTD | |
| G | Cuta | cutA divalent cation tolerance homolog (E. coli) |
|
decreases expression | ISO | 20 | 5,175,113 | 5,176,689 | RGD:6480464 | CTD | |
| G | Cutc | cutC copper transporter homolog (E.coli) |
|
multiple interactions | ISO | 1 | 247,062,300 | 247,077,070 | RGD:6480464 | CTD | |
| G | Cux1 | cut-like homeobox 1 |
|
multiple interactions | ISO | 12 | 21,223,919 | 21,516,938 | RGD:6480464 | CTD | |
| G | Cux1 | cut-like homeobox 1 |
|
multiple interactions | ISO | 12 | 21,223,919 | 21,516,938 | RGD:6480464 | CTD | |
| G | Cux2 | cut-like homeobox 2 |
|
decreases expression | ISO | 12 | 35,850,093 | 35,910,414 | RGD:6480464 | CTD | |
| G | Cux2 | cut-like homeobox 2 |
|
multiple interactions | ISO | 12 | 35,850,093 | 35,910,414 | RGD:6480464 | CTD | |
| G | Cx3cl1 | chemokine (C-X3-C motif) ligand 1 |
|
multiple interactions | ISO | 19 | 10,666,940 | 10,676,424 | RGD:6480464 | CTD | |
| G | Cx3cl1 | chemokine (C-X3-C motif) ligand 1 |
|
multiple interactions | ISO | 19 | 10,666,940 | 10,676,424 | RGD:6480464 | CTD | |
| G | Cx3cl1 | chemokine (C-X3-C motif) ligand 1 |
|
decreases expression | ISO | 19 | 10,666,940 | 10,676,424 | RGD:6480464 | CTD | |
| G | Cxadr | coxsackie virus and adenovirus receptor |
|
decreases expression | ISO | 11 | 17,193,505 | 17,241,549 | RGD:6480464 | CTD | |
| G | Cxcl1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions | ISO | 14 | 18,690,339 | 18,692,118 | RGD:6480464 | CTD | |
| G | Cxcl1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions | ISO | 14 | 18,690,339 | 18,692,118 | RGD:6480464 | CTD | |
| G | Cxcl1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions | ISO | 14 | 18,690,339 | 18,692,118 | RGD:6480464 | CTD | |
| G | Cxcl1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions | ISO | 14 | 18,690,339 | 18,692,118 | RGD:6480464 | CTD | |
| G | Cxcl1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression | ISO | 14 | 18,690,339 | 18,692,118 | RGD:6480464 | CTD | |
| G | Cxcl10 | chemokine (C-X-C motif) ligand 10 |
|
decreases expression | ISO | 14 | 17,265,986 | 17,268,183 | RGD:6480464 | CTD | |
| G | Cxcl10 | chemokine (C-X-C motif) ligand 10 |
|
multiple interactions | ISO | 14 | 17,265,986 | 17,268,183 | RGD:6480464 | CTD | |
| G | Cxcl10 | chemokine (C-X-C motif) ligand 10 |
|
increases expression | EXP | 14 | 17,265,986 | 17,268,183 | RGD:6480464 | CTD | |
| G | Cxcl12 | chemokine (C-X-C motif) ligand 12 |
|
multiple interactions | ISO | 4 | 153,503,576 | 153,516,423 | RGD:6480464 | CTD | |
| G | Cxcl12 | chemokine (C-X-C motif) ligand 12 |
|
decreases expression | ISO | 4 | 153,503,576 | 153,516,423 | RGD:6480464 | CTD | |
| G | Cxcl12 | chemokine (C-X-C motif) ligand 12 |
|
decreases expression | ISO | 4 | 153,503,576 | 153,516,423 | RGD:6480464 | CTD | |
| G | Cxcl12 | chemokine (C-X-C motif) ligand 12 |
|
increases expression | ISO | 4 | 153,503,576 | 153,516,423 | RGD:6480464 | CTD | |
| G | Cxcl12 | chemokine (C-X-C motif) ligand 12 |
|
multiple interactions | ISO | 4 | 153,503,576 | 153,516,423 | RGD:6480464 | CTD | |
| G | Cxcl12 | chemokine (C-X-C motif) ligand 12 |
|
multiple interactions | ISO | 4 | 153,503,576 | 153,516,423 | RGD:6480464 | CTD | |
| G | Cxcl12 | chemokine (C-X-C motif) ligand 12 |
|
multiple interactions | ISO | 4 | 153,503,576 | 153,516,423 | RGD:6480464 | CTD | |
| G | Cyp11b1 | cytochrome P450, family 11, subfamily b, polypeptide 1 |
|
decreases expression | EXP | 7 | 112,977,395 | 112,984,080 | RGD:6480464 | CTD | |
| G | Cyp11b2 | cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
decreases expression | ISO | 7 | 113,043,365 | 113,049,779 | RGD:6480464 | CTD | |
| G | Cyp17a1 | cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
multiple interactions | EXP | 1 | 251,965,458 | 251,971,449 | RGD:6480464 | CTD | |
| G | Cyp17a1 | cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
decreases expression | EXP | 1 | 251,965,458 | 251,971,449 | RGD:6480464 | CTD | |
| G | Cyp17a1 | cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
decreases expression | EXP | 1 | 251,965,458 | 251,971,449 | RGD:6480464 | CTD | |
| G | Cyp19a1 | cytochrome P450, family 19, subfamily a, polypeptide 1 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Cyp19a1 | cytochrome P450, family 19, subfamily a, polypeptide 1 | affects activity | ISO | RGD:6480464 | CTD | |||||
| G | Cyp19a1 | cytochrome P450, family 19, subfamily a, polypeptide 1 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Cyp19a1 | cytochrome P450, family 19, subfamily a, polypeptide 1 | increases activity | ISO | RGD:6480464 | CTD | |||||
| G | Cyp19a1 | cytochrome P450, family 19, subfamily a, polypeptide 1 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Cyp19a1 | cytochrome P450, family 19, subfamily a, polypeptide 1 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Cyp19a1 | cytochrome P450, family 19, subfamily a, polypeptide 1 | increases stability | ISO | RGD:6480464 | CTD | |||||
| G | Cyp19a1 | cytochrome P450, family 19, subfamily a, polypeptide 1 | affects expression | EXP | RGD:6480464 | CTD | |||||
| G | Cyp19a1 | cytochrome P450, family 19, subfamily a, polypeptide 1 | multiple interactions | EXP | RGD:6480464 | CTD | |||||
| G | Cyp19a1 | cytochrome P450, family 19, subfamily a, polypeptide 1 | decreases activity | EXP | RGD:6480464 | CTD | |||||
| G | Cyp19a1 | cytochrome P450, family 19, subfamily a, polypeptide 1 | decreases expression | EXP | RGD:6480464 | CTD | |||||
| G | Cyp19a1 | cytochrome P450, family 19, subfamily a, polypeptide 1 | increases expression | EXP | RGD:6480464 | CTD | |||||
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp2c11 | cytochrome P450, subfamily 2, polypeptide 11 |
|
increases expression | ISO | 1 | 243,281,320 | 243,320,945 | RGD:6480464 | CTD | |
| G | Cyp2c11 | cytochrome P450, subfamily 2, polypeptide 11 |
|
multiple interactions | ISO | 1 | 243,281,320 | 243,320,945 | RGD:6480464 | CTD | |
| G | Cyp2c11 | cytochrome P450, subfamily 2, polypeptide 11 |
|
increases expression | ISO | 1 | 243,281,320 | 243,320,945 | RGD:6480464 | CTD | |
| G | Cyp2c11 | cytochrome P450, subfamily 2, polypeptide 11 |
|
decreases expression | ISO | 1 | 243,281,320 | 243,320,945 | RGD:6480464 | CTD | |
| G | Cyp2c6v1 | cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
|
multiple interactions | ISO | 1 | 243,859,015 | 243,896,003 | RGD:6480464 | CTD | |
| G | Cyp2c6v1 | cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
|
decreases expression | ISO | 1 | 243,859,015 | 243,896,003 | RGD:6480464 | CTD | |
| G | Cyp3a23/3a1 | cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
decreases expression | ISO | 12 | 9,567,120 | 9,595,974 | RGD:6480464 | CTD | |
| G | Cystm1 | cysteine-rich transmembrane module containing 1 |
|
increases expression | ISO | 18 | 28,984,344 | 29,031,445 | RGD:6480464 | CTD | |
| G | Ddx3y | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3 Y-linked |
|
multiple interactions | ISO | X | 21,498,202 | 21,505,416 | RGD:6480464 | CTD | |
| G | Ddx3y | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3 Y-linked |
|
multiple interactions | ISO | X | 21,498,202 | 21,505,416 | RGD:6480464 | CTD | |
| G | Ddx3y | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3 Y-linked |
|
increases expression | ISO | X | 21,498,202 | 21,505,416 | RGD:6480464 | CTD | |
| G | Denr | density-regulated protein |
|
decreases expression | ISO | 12 | 33,797,483 | 33,819,744 | RGD:6480464 | CTD | |
| G | Dexi | dexamethasone-induced transcript |
|
decreases expression | ISO | 10 | 5,072,036 | 5,084,723 | RGD:6480464 | CTD | |
| G | Dhx29 | DEAH (Asp-Glu-Ala-His) box polypeptide 29 |
|
multiple interactions | ISO | 2 | 44,306,480 | 44,357,742 | RGD:6480464 | CTD | |
| G | Diablo | diablo, IAP-binding mitochondrial protein |
|
affects expression | ISO | 12 | 34,196,347 | 34,209,633 | RGD:6480464 | CTD | |
| G | Dock7 | dedicator of cytokinesis 7 |
|
decreases expression | ISO | 5 | 119,377,149 | 119,535,973 | RGD:6480464 | CTD | |
| G | Dock7 | dedicator of cytokinesis 7 |
|
increases expression | ISO | 5 | 119,377,149 | 119,535,973 | RGD:6480464 | CTD | |
| G | Dos | downstream of Stk11 |
|
decreases expression | ISO | 7 | 11,079,431 | 11,087,057 | RGD:6480464 | CTD | |
| G | Drosha | drosha, ribonuclease type III |
|
multiple interactions | ISO | 2 | 62,336,007 | 62,447,618 | RGD:6480464 | CTD | |
| G | Dsc1 | desmocollin 1 |
|
increases expression | ISO | 18 | 11,953,172 | 11,979,048 | RGD:6480464 | CTD | |
| G | Dtnbp1 | dystrobrevin binding protein 1 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Dtnbp1 | dystrobrevin binding protein 1 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Dtnbp1 | dystrobrevin binding protein 1 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Dusp13 | dual specificity phosphatase 13 |
|
multiple interactions | ISO | 15 | 2,614,864 | 2,630,230 | RGD:6480464 | CTD | |
| G | E2f4 | E2F transcription factor 4, p107/p130-binding |
|
multiple interactions | ISO | 19 | 35,112,273 | 35,118,888 | RGD:6480464 | CTD | |
| G | Eapp | E2F-associated phosphoprotein |
|
multiple interactions | ISO | 6 | 74,985,403 | 75,012,635 | RGD:6480464 | CTD | |
| G | Edc3 | enhancer of mRNA decapping 3 homolog (S. cerevisiae) |
|
multiple interactions | ISO | 8 | 61,472,266 | 61,517,590 | RGD:6480464 | CTD | |
| G | Edc3 | enhancer of mRNA decapping 3 homolog (S. cerevisiae) |
|
increases expression | ISO | 8 | 61,472,266 | 61,517,590 | RGD:6480464 | CTD | |
| G | Edc3 | enhancer of mRNA decapping 3 homolog (S. cerevisiae) |
|
increases expression | ISO | 8 | 61,472,266 | 61,517,590 | RGD:6480464 | CTD | |
| G | Eif1 | eukaryotic translation initiation factor 1 |
|
multiple interactions | ISO | 10 | 89,255,637 | 89,257,728 | RGD:6480464 | CTD | |
| G | Eif1l1 | eukaryotic translation initiation factor 1-like 1 |
|
multiple interactions | ISO | 5 | 21,736,137 | 21,736,478 | RGD:6480464 | CTD | |
| G | Eif2s3y | eukaryotic translation initiation factor 2, subunit 3, structural gene Y-linked |
|
increases expression | ISO | 2 | 102,222,332 | 102,223,486 | RGD:6480464 | CTD | |
| G | Eif5b | eukaryotic translation initiation factor 5B |
|
decreases expression | ISO | 9 | 36,937,415 | 36,993,650 | RGD:6480464 | CTD | |
| G | Elovl2 | ELOVL fatty acid elongase 2 |
|
multiple interactions | ISO | 17 | 29,492,349 | 29,532,622 | RGD:6480464 | CTD | |
| G | Elovl2 | ELOVL fatty acid elongase 2 |
|
increases expression | ISO | 17 | 29,492,349 | 29,532,622 | RGD:6480464 | CTD | |
| G | Elovl2 | ELOVL fatty acid elongase 2 |
|
decreases expression | ISO | 17 | 29,492,349 | 29,532,622 | RGD:6480464 | CTD | |
| G | Elovl2 | ELOVL fatty acid elongase 2 |
|
multiple interactions | ISO | 17 | 29,492,349 | 29,532,622 | RGD:6480464 | CTD | |
| G | Elp3 | elongator acetyltransferase complex subunit 3 |
|
decreases expression | ISO | 15 | 44,958,714 | 45,020,426 | RGD:6480464 | CTD | |
| G | Elp3 | elongator acetyltransferase complex subunit 3 |
|
increases expression | ISO | 15 | 44,958,714 | 45,020,426 | RGD:6480464 | CTD | |
| G | Elp3 | elongator acetyltransferase complex subunit 3 |
|
increases expression | ISO | 15 | 44,958,714 | 45,020,426 | RGD:6480464 | CTD | |
| G | Endod1 | endonuclease domain containing 1 |
|
decreases expression | ISO | 8 | 11,151,051 | 11,180,463 | RGD:6480464 | CTD | |
| G | Endod1 | endonuclease domain containing 1 |
|
increases expression | ISO | 8 | 11,151,051 | 11,180,463 | RGD:6480464 | CTD | |
| G | Enpep | glutamyl aminopeptidase |
|
decreases expression | ISO | 2 | 226,731,079 | 226,732,069 | RGD:6480464 | CTD | |
| G | Enpep | glutamyl aminopeptidase |
|
multiple interactions | ISO | 2 | 226,731,079 | 226,732,069 | RGD:6480464 | CTD | |
| G | Epc1 | enhancer of polycomb homolog 1 (Drosophila) |
|
affects expression | ISO | 17 | 63,040,151 | 63,131,954 | RGD:6480464 | CTD | |
| G | Epc1 | enhancer of polycomb homolog 1 (Drosophila) |
|
increases expression | ISO | 17 | 63,040,151 | 63,131,954 | RGD:6480464 | CTD | |
| G | Evi5l | ecotropic viral integration site 5-like |
|
affects expression | ISO | 12 | 1,587,281 | 1,625,271 | RGD:6480464 | CTD | |
| G | Ext2 | exostosin glycosyltransferase 2 |
|
decreases expression | ISO | 3 | 78,111,436 | 78,244,444 | RGD:6480464 | CTD | |
| G | Ext2 | exostosin glycosyltransferase 2 |
|
multiple interactions | ISO | 3 | 78,111,436 | 78,244,444 | RGD:6480464 | CTD | |
| G | Ext2 | exostosin glycosyltransferase 2 |
|
multiple interactions | ISO | 3 | 78,111,436 | 78,244,444 | RGD:6480464 | CTD | |
| G | Fam208b | family with sequence similarity 208, member B |
|
decreases expression | ISO | 17 | 77,806,664 | 77,842,055 | RGD:6480464 | CTD | |
| G | Fam69b | family with sequence similarity 69, member B |
|
increases expression | ISO | 3 | 4,809,288 | 4,817,041 | RGD:6480464 | CTD | |
| G | Fbn2 | fibrillin 2 |
|
multiple interactions | ISO | 18 | 53,883,011 | 53,914,001 | RGD:6480464 | CTD | |
| G | Fbxo18 | F-box protein, helicase, 18 |
|
multiple interactions | ISO | 17 | 77,945,025 | 77,982,314 | RGD:6480464 | CTD | |
| G | Fbxo18 | F-box protein, helicase, 18 |
|
increases expression | ISO | 17 | 77,945,025 | 77,982,314 | RGD:6480464 | CTD | |
| G | Fbxw7 | F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
|
multiple interactions | ISO | 2 | 176,675,226 | 176,750,737 | RGD:6480464 | CTD | |
| G | Fbxw7 | F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
|
multiple interactions | ISO | 2 | 176,675,226 | 176,750,737 | RGD:6480464 | CTD | |
| G | Fhod3 | formin homology 2 domain containing 3 |
|
increases expression | ISO | 18 | 16,487,052 | 16,952,424 | RGD:6480464 | CTD | |
| G | Fhod3 | formin homology 2 domain containing 3 |
|
increases expression | ISO | 18 | 16,487,052 | 16,952,424 | RGD:6480464 | CTD | |
| G | Fhod3 | formin homology 2 domain containing 3 |
|
decreases expression | ISO | 18 | 16,487,052 | 16,952,424 | RGD:6480464 | CTD | |
| G | Foxc1 | forkhead box C1 |
|
decreases expression | ISO | 17 | 39,026,186 | 39,030,163 | RGD:6480464 | CTD | |
| G | Foxc2 | forkhead box C2 | decreases expression | ISO | RGD:6480464 | CTD | |||||
| G | Foxc2 | forkhead box C2 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Foxc2 | forkhead box C2 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Foxp4 | forkhead box P4 |
|
affects expression | ISO | 9 | 8,509,028 | 8,579,597 | RGD:6480464 | CTD | |
| G | Foxp4 | forkhead box P4 |
|
multiple interactions | ISO | 9 | 8,509,028 | 8,579,597 | RGD:6480464 | CTD | |
| G | Frg1 | FSHD region gene 1 |
|
multiple interactions | ISO | 16 | 54,237,736 | 54,259,311 | RGD:6480464 | CTD | |
| G | Frg1 | FSHD region gene 1 |
|
multiple interactions | ISO | 16 | 54,237,736 | 54,259,311 | RGD:6480464 | CTD | |
| G | Fubp1 | far upstream element (FUSE) binding protein 1 |
|
multiple interactions | ISO | 2 | 250,749,095 | 250,777,521 | RGD:6480464 | CTD | |
| G | Fubp1 | far upstream element (FUSE) binding protein 1 |
|
multiple interactions | ISO | 2 | 250,749,095 | 250,777,521 | RGD:6480464 | CTD | |
| G | Fubp1 | far upstream element (FUSE) binding protein 1 |
|
increases expression | ISO | 2 | 250,749,095 | 250,777,521 | RGD:6480464 | CTD | |
| G | Fzd7 | frizzled family receptor 7 |
|
increases expression | ISO | 9 | 58,063,740 | 58,066,559 | RGD:6480464 | CTD | |
| G | Gal3st1 | galactose-3-O-sulfotransferase 1 |
|
increases expression | ISO | 14 | 84,636,490 | 84,642,269 | RGD:6480464 | CTD | |
| G | Garnl3 | GTPase activating Rap/RanGAP domain-like 3 |
|
multiple interactions | ISO | 3 | 11,976,369 | 12,076,318 | RGD:6480464 | CTD | |
| G | Gcc1 | GRIP and coiled-coil domain containing 1 |
|
increases expression | ISO | 4 | 55,287,931 | 55,291,642 | RGD:6480464 | CTD | |
| G | Gem | GTP binding protein overexpressed in skeletal muscle |
|
decreases expression | ISO | 5 | 25,809,543 | 26,008,249 | RGD:6480464 | CTD | |
| G | Gem | GTP binding protein overexpressed in skeletal muscle |
|
multiple interactions | ISO | 5 | 25,809,543 | 26,008,249 | RGD:6480464 | CTD | |
| G | Gem | GTP binding protein overexpressed in skeletal muscle |
|
increases expression | ISO | 5 | 25,809,543 | 26,008,249 | RGD:6480464 | CTD | |
| G | Glipr1l2 | GLI pathogenesis-related 1 like 2 |
|
multiple interactions | ISO | 7 | 51,111,128 | 51,140,614 | RGD:6480464 | CTD | |
| G | Golm1 | golgi membrane protein 1 |
|
multiple interactions | ISO | 17 | 10,911,513 | 10,938,960 | RGD:6480464 | CTD | |
| G | Golm1 | golgi membrane protein 1 |
|
decreases expression | ISO | 17 | 10,911,513 | 10,938,960 | RGD:6480464 | CTD | |
| G | Gpr17 | G protein-coupled receptor 17 |
|
multiple interactions | ISO | 18 | 24,374,253 | 24,375,272 | RGD:6480464 | CTD | |
| G | Grcc10 | gene rich cluster, C10 gene |
|
decreases expression | ISO | 4 | 160,869,349 | 160,870,984 | RGD:6480464 | CTD | |
| G | Gsta5 | glutathione S-transferase alpha 5 |
|
increases expression | EXP | 8 | 83,202,554 | 83,211,997 | RGD:6480464 | CTD | |
| G | Gvinp1 | GTPase, very large interferon inducible 1 |
|
decreases expression | ISO | 1 | 163,589,101 | 163,598,317 | RGD:6480464 | CTD | |
| G | Hbb-b1 | hemoglobin, beta adult major chain |
|
increases expression | ISO | 1 | 161,590,671 | 161,598,127 | RGD:6480464 | CTD | |
| G | Hbz | hemoglobin, zeta |
|
decreases expression | ISO | 10 | 15,590,914 | 15,592,386 | RGD:6480464 | CTD | |
| G | Hbz | hemoglobin, zeta |
|
multiple interactions | ISO | 10 | 15,590,914 | 15,592,386 | RGD:6480464 | CTD | |
| G | Hdac5 | histone deacetylase 5 |
|
decreases expression | ISO | 10 | 91,266,512 | 91,277,705 | RGD:6480464 | CTD | |
| G | Heg1 | heart development protein with EGF-like domains 1 |
|
decreases expression | ISO | 11 11 |
68,828,748 68,828,748 |
68,889,177 68,912,073 |
RGD:6480464 | CTD | |
| G | Heg1 | heart development protein with EGF-like domains 1 |
|
increases expression | ISO | 11 11 |
68,828,748 68,828,748 |
68,889,177 68,912,073 |
RGD:6480464 | CTD | |
| G | Heg1 | heart development protein with EGF-like domains 1 |
|
multiple interactions | ISO | 11 11 |
68,828,748 68,828,748 |
68,889,177 68,912,073 |
RGD:6480464 | CTD | |
| G | Hhat | hedgehog acyltransferase |
|
increases expression | ISO | 13 | 108,411,459 | 108,651,307 | RGD:6480464 | CTD | |
| G | Higd1a | HIG1 hypoxia inducible domain family, member 1A |
|
decreases expression | ISO | 8 | 127,076,654 | 127,085,885 | RGD:6480464 | CTD | |
| G | Hist1h2bg | histone cluster 1, H2bg |
|
increases expression | ISO | 17 | 48,771,873 | 48,772,253 | RGD:6480464 | CTD | |
| G | Hist1h2bh | histone cluster 1, H2bh |
|
increases expression | ISO | 17 | 50,111,215 | 50,111,595 | RGD:6480464 | CTD | |
| G | Hist1h2bl | histone cluster 1, H2bl |
|
decreases expression | EXP | 17 | 50,343,037 | 50,343,698 | RGD:6480464 | CTD | |
| G | Hist1h2bo | histone cluster 1, H2bo |
|
affects expression | ISO | 17 | 50,350,860 | 50,352,473 | RGD:6480464 | CTD | |
| G | Hist1h3h | histone cluster 1, H3h |
|
increases expression | ISO | 17 | 50,357,901 | 50,358,311 | RGD:6480464 | CTD | |
| G | Hist3h3 | histone cluster 3, H3 |
|
multiple interactions | ISO | 10 | 45,252,993 | 45,253,403 | RGD:6480464 | CTD | |
| G | Hist3h3 | histone cluster 3, H3 |
|
increases acetylation | ISO | 10 | 45,252,993 | 45,253,403 | RGD:6480464 | CTD | |
| G | Hoxa9 | homeobox A9 |
|
decreases expression | ISO | 4 | 80,524,246 | 80,526,491 | RGD:6480464 | CTD | |
| G | Hoxb2 | homeobox B2 |
|
decreases expression | ISO | 10 | 85,085,425 | 85,087,617 | RGD:6480464 | CTD | |
| G | Hspa1a | heat shock protein 1A |
|
increases expression | ISO | 20 | 3,945,716 | 3,959,552 | RGD:6480464 | CTD | |
| G | Hspa1a | heat shock protein 1A |
|
multiple interactions | ISO | 20 | 3,945,716 | 3,959,552 | RGD:6480464 | CTD | |
| G | Hspa1a | heat shock protein 1A |
|
affects expression | ISO | 20 | 3,945,716 | 3,959,552 | RGD:6480464 | CTD | |
| G | Hspa1a | heat shock protein 1A |
|
multiple interactions | ISO | 20 | 3,945,716 | 3,959,552 | RGD:6480464 | CTD | |
| G | Hspe1 | heat shock protein 1 (chaperonin 10) |
|
multiple interactions | ISO | 9 | 53,895,333 | 53,898,421 | RGD:6480464 | CTD | |
| G | Hspe1 | heat shock protein 1 (chaperonin 10) |
|
increases expression | ISO | 9 | 53,895,333 | 53,898,421 | RGD:6480464 | CTD | |
| G | Hspg2 | heparan sulfate proteoglycan 2 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Hspg2 | heparan sulfate proteoglycan 2 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Hyi | hydroxypyruvate isomerase |
|
decreases expression | ISO | 5 | 138,842,872 | 138,843,826 | RGD:6480464 | CTD | |
| G | Icos | inducible T-cell co-stimulator | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Icos | inducible T-cell co-stimulator | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Iffo2 | intermediate filament family orphan 2 |
|
multiple interactions | ISO | 5 | 158,404,342 | 158,418,394 | RGD:6480464 | CTD | |
| G | Iffo2 | intermediate filament family orphan 2 |
|
increases expression | ISO | 5 | 158,404,342 | 158,418,394 | RGD:6480464 | CTD | |
| G | Ifi27l2b | interferon, alpha-inducible protein 27 like 2B |
|
increases expression | ISO | 6 | 127,733,540 | 127,735,026 | RGD:6480464 | CTD | |
| G | Ifitm1 | interferon induced transmembrane protein 1 |
|
increases expression | ISO | 1 | 201,154,494 | 201,155,509 | RGD:6480464 | CTD | |
| G | Ifitm1 | interferon induced transmembrane protein 1 |
|
decreases expression | ISO | 1 | 201,154,494 | 201,155,509 | RGD:6480464 | CTD | |
| G | Ifitm1 | interferon induced transmembrane protein 1 |
|
multiple interactions | ISO | 1 | 201,154,494 | 201,155,509 | RGD:6480464 | CTD | |
| G | Ifitm1 | interferon induced transmembrane protein 1 |
|
multiple interactions | ISO | 1 | 201,154,494 | 201,155,509 | RGD:6480464 | CTD | |
| G | Ift140 | intraflagellar transport 140 |
|
decreases expression | ISO | 10 | 14,258,556 | 14,348,468 | RGD:6480464 | CTD | |
| G | Il12rb1 | interleukin 12 receptor, beta 1 |
|
increases expression | ISO | 16 | 19,126,653 | 19,137,584 | RGD:6480464 | CTD | |
| G | Ilf2 | interleukin enhancer binding factor 2 |
|
multiple interactions | ISO | 2 | 182,741,739 | 182,761,593 | RGD:6480464 | CTD | |
| G | Ipo11 | importin 11 |
|
affects expression | ISO | 2 | 38,006,409 | 38,054,430 | RGD:6480464 | CTD | |
| G | Ipo11 | importin 11 |
|
multiple interactions | ISO | 2 | 38,006,409 | 38,054,430 | RGD:6480464 | CTD | |
| G | Itga3 | integrin, alpha 3 |
|
affects expression | ISO | 10 | 83,728,710 | 83,759,576 | RGD:6480464 | CTD | |
| G | Kank2 | KN motif and ankyrin repeat domains 2 |
|
increases expression | ISO | 8 | 20,865,615 | 20,892,573 | RGD:6480464 | CTD | |
| G | Kbtbd6 | kelch repeat and BTB (POZ) domain containing 6 |
|
decreases expression | ISO | 15 | 61,501,576 | 61,503,070 | RGD:6480464 | CTD | |
| G | Kcnk7 | potassium channel, subfamily K, member 7 |
|
multiple interactions | ISO | 1 | 208,327,893 | 208,330,476 | RGD:6480464 | CTD | |
| G | Kctd3 | potassium channel tetramerisation domain containing 3 |
|
multiple interactions | ISO | 13 | 105,117,483 | 105,155,705 | RGD:6480464 | CTD | |
| G | Kdm4b | lysine (K)-specific demethylase 4B | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Kdm5a | lysine (K)-specific demethylase 5A |
|
multiple interactions | ISO | 4 | 156,736,343 | 156,811,991 | RGD:6480464 | CTD | |
| G | Klhdc7a | kelch domain containing 7A |
|
decreases expression | ISO | 5 | 158,751,700 | 158,754,021 | RGD:6480464 | CTD | |
| G | Kntc1 | kinetochore associated 1 |
|
increases expression | ISO | 12 | 33,906,847 | 33,977,070 | RGD:6480464 | CTD | |
| G | Krr1 | KRR1, small subunit (SSU) processome component, homolog (yeast) |
|
decreases expression | ISO | 7 | 51,069,927 | 51,081,361 | RGD:6480464 | CTD | |
| G | Krr1 | KRR1, small subunit (SSU) processome component, homolog (yeast) |
|
multiple interactions | ISO | 7 | 51,069,927 | 51,081,361 | RGD:6480464 | CTD | |
| G | Krr1 | KRR1, small subunit (SSU) processome component, homolog (yeast) |
|
decreases methylation | ISO | 7 | 51,069,927 | 51,081,361 | RGD:6480464 | CTD | |
| G | Krt81 | keratin 81 |
|
multiple interactions | ISO | 7 | 140,208,280 | 140,213,180 | RGD:6480464 | CTD | |
| G | Krt81 | keratin 81 |
|
increases expression | ISO | 7 | 140,208,280 | 140,213,180 | RGD:6480464 | CTD | |
| G | Ktn1 | kinectin 1 (kinesin receptor) |
|
multiple interactions | ISO | 15 | 23,633,479 | 23,722,293 | RGD:6480464 | CTD | |
| G | Ktn1 | kinectin 1 (kinesin receptor) |
|
increases expression | ISO | 15 | 23,633,479 | 23,722,293 | RGD:6480464 | CTD | |
| G | Lace1 | lactation elevated 1 |
|
multiple interactions | ISO | 20 | 46,296,402 | 46,302,522 | RGD:6480464 | CTD | |
| G | Lce3d | late cornified envelope 3D |
|
decreases expression | ISO | 2 | 185,964,395 | 185,964,691 | RGD:6480464 | CTD | |
| G | Lcorl | ligand dependent nuclear receptor corepressor-like |
|
increases expression | ISO | 14 | 70,330,344 | 70,435,179 | RGD:6480464 | CTD | |
| G | Ldb3 | LIM domain binding 3 |
|
increases expression | ISO | 16 | 10,221,362 | 10,247,798 | RGD:6480464 | CTD | |
| G | Lingo2 | leucine rich repeat and Ig domain containing 2 |
|
multiple interactions | ISO | 5 | 52,476,741 | 52,590,042 | RGD:6480464 | CTD | |
| G | Lingo2 | leucine rich repeat and Ig domain containing 2 |
|
decreases methylation | ISO | 5 | 52,476,741 | 52,590,042 | RGD:6480464 | CTD | |
| G | LOC100233176 | hypothetical protein LOC100233176 |
|
increases expression | ISO | 6 | 127,014,007 | 127,031,009 | RGD:6480464 | CTD | |
| G | LOC100302372 | hypothetical protein LOC100302372 |
|
decreases expression | ISO | 13 | 75,458,253 | 75,495,823 | RGD:6480464 | CTD | |
| G | LOC100360218 | interleukin 13 receptor, alpha 1-like |
|
decreases expression | ISO | 11 | 73,147,318 | 73,148,958 | RGD:6480464 | CTD | |
| G | LOC100360218 | interleukin 13 receptor, alpha 1-like |
|
decreases expression | ISO | 11 | 73,147,318 | 73,148,958 | RGD:6480464 | CTD | |
| G | LOC100360920 | KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
|
multiple interactions | ISO | 12 | 11,498,420 | 11,513,595 | RGD:6480464 | CTD | |
| G | LOC100360920 | KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
|
increases expression | ISO | 12 | 11,498,420 | 11,513,595 | RGD:6480464 | CTD | |
| G | LOC100360940 | diablo-like |
|
affects expression | ISO | 5 | 148,562,065 | 148,563,619 | RGD:6480464 | CTD | |
| G | LOC100362888 | rCG52099-like |
|
decreases expression | ISO | 15 | 41,841,298 | 41,844,727 | RGD:6480464 | CTD | |
| G | LOC498685 | similar to UPF0308 protein C9orf21 |
|
increases expression | ISO | 17 | 6,336,052 | 6,370,548 | RGD:6480464 | CTD | |
| G | LOC686736 | similar to H3 histone, family 3B |
|
multiple interactions | ISO | 1 | 212,798,225 | 212,798,635 | RGD:6480464 | CTD | |
| G | LOC686736 | similar to H3 histone, family 3B |
|
multiple interactions | ISO | 1 | 212,798,225 | 212,798,635 | RGD:6480464 | CTD | |
| G | LOC691931 | hypothetical protein LOC691931 |
|
increases expression | ISO | 2 | 225,153,751 | 225,184,430 | RGD:6480464 | CTD | |
| G | Lrp11 | low density lipoprotein receptor-related protein 11 |
|
increases expression | ISO | 1 | 2,255,892 | 2,284,328 | RGD:6480464 | CTD | |
| G | Lrp11 | low density lipoprotein receptor-related protein 11 |
|
multiple interactions | ISO | 1 | 2,255,892 | 2,284,328 | RGD:6480464 | CTD | |
| G | Lrp3 | low density lipoprotein receptor-related protein 3 |
|
decreases expression | ISO | 1 | 87,711,390 | 87,725,636 | RGD:6480464 | CTD | |
| G | Lrrfip1 | leucine rich repeat (in FLII) interacting protein 1 |
|
multiple interactions | ISO | 9 | 90,278,891 | 90,346,980 | RGD:6480464 | CTD | |
| G | Lyrm5 | LYR motif containing 5 |
|
increases expression | ISO | 4 | 182,859,926 | 182,865,036 | RGD:6480464 | CTD | |
| G | Lyrm7 | LYR motif containing 7 |
|
decreases expression | ISO | 10 | 40,246,614 | 40,265,653 | RGD:6480464 | CTD | |
| G | Lztfl1 | leucine zipper transcription factor-like 1 |
|
increases expression | ISO | 8 | 128,474,651 | 128,489,845 | RGD:6480464 | CTD | |
| G | Macf1 | microtubule-actin crosslinking factor 1 |
|
multiple interactions | ISO | 5 | 142,659,726 | 142,986,873 | RGD:6480464 | CTD | |
| G | Macf1 | microtubule-actin crosslinking factor 1 |
|
increases expression | ISO | 5 | 142,659,726 | 142,986,873 | RGD:6480464 | CTD | |
| G | Map3k5 | mitogen-activated protein kinase kinase kinase 5 |
|
multiple interactions | ISO | 1 | 15,205,361 | 15,346,422 | RGD:6480464 | CTD | |
| G | Map3k5 | mitogen-activated protein kinase kinase kinase 5 |
|
decreases expression | ISO | 1 | 15,205,361 | 15,346,422 | RGD:6480464 | CTD | |
| G | Map4k4 | mitogen-activated protein kinase kinase kinase kinase 4 |
|
decreases expression | ISO | 9 | 39,087,924 | 39,213,053 | RGD:6480464 | CTD | |
| G | Med13l | mediator complex subunit 13-like |
|
affects expression | ISO | 12 | 39,136,265 | 39,181,221 | RGD:6480464 | CTD | |
| G | Med13l | mediator complex subunit 13-like |
|
decreases expression | ISO | 12 | 39,136,265 | 39,181,221 | RGD:6480464 | CTD | |
| G | Mlxipl | MLX interacting protein-like | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Mmab | methylmalonic aciduria (cobalamin deficiency) cblB type | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Mt-co1 | mitochondrially encoded cytochrome c oxidase I |
|
decreases expression | ISO | MT | 5,323 | 6,867 | RGD:6480464 | CTD | |
| G | Mt-co2 | mitochondrially encoded cytochrome c oxidase II |
|
multiple interactions | ISO | MT | 7,006 | 7,689 | RGD:6480464 | CTD | |
| G | Mt-co2 | mitochondrially encoded cytochrome c oxidase II |
|
decreases expression | ISO | MT | 7,006 | 7,689 | RGD:6480464 | CTD | |
| G | Ndufa11 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 11 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Ndufa7 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 |
|
affects expression | ISO | 7 | 16,322,027 | 16,334,210 | RGD:6480464 | CTD | |
| G | Ndufb3 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex 3 |
|
increases expression | ISO | 9 | 57,252,769 | 57,262,981 | RGD:6480464 | CTD | |
| G | Ndufb4 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex 4 |
|
affects expression | ISO | 11 | 64,852,589 | 64,859,550 | RGD:6480464 | CTD | |
| G | Nmrk1 | nicotinamide riboside kinase 1 |
|
decreases expression | ISO | 1 | 222,230,110 | 222,257,462 | RGD:6480464 | CTD | |
| G | Nxpe2 | neurexophilin and PC-esterase domain family, member 2 |
|
multiple interactions | ISO | 8 | 51,611,643 | 51,623,632 | RGD:6480464 | CTD | |
| G | Phf11 | PHD finger protein 11 |
|
multiple interactions | ISO | 15 | 38,443,971 | 38,477,944 | RGD:6480464 | CTD | |
| G | Rasa3 | RAS p21 protein activator 3 |
|
increases expression | ISO | 16 | 80,710,463 | 80,824,220 | RGD:6480464 | CTD | |
| G | RGD1304595 | similar to RIKEN cDNA 6330416G13 gene |
|
decreases expression | ISO | 5 | 80,531,483 | 80,555,551 | RGD:6480464 | CTD | |
| G | RGD1308117 | similar to 9930012K11Rik protein |
|
increases expression | ISO | 15 | 50,555,250 | 50,559,887 | RGD:6480464 | CTD | |
| G | RGD1565059 | similar to hypothetical protein E130311K13 |
|
decreases expression | ISO | 2 | 153,709,289 | 153,733,281 | RGD:6480464 | CTD | |
| G | Rora | RAR-related orphan receptor A |
|
affects expression | ISO | 8 | 73,052,282 | 73,817,764 | RGD:6480464 | CTD | |
| G | Rora | RAR-related orphan receptor A |
|
decreases expression | ISO | 8 | 73,052,282 | 73,817,764 | RGD:6480464 | CTD | |
| G | Rpl17 | ribosomal protein L17 |
|
multiple interactions | ISO | 18 | 71,863,062 | 71,866,168 | RGD:6480464 | CTD | |
| G | Rps10 | ribosomal protein S10 |
|
decreases expression | ISO | 20 | 5,849,327 | 5,853,893 | RGD:6480464 | CTD | |
| G | Rps27l | ribosomal protein S27-like | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Rps27l | ribosomal protein S27-like | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Rps27l | ribosomal protein S27-like | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | RT1-CE7 | RT1 class I, locus CE7 |
|
decreases expression | ISO | 20 | 3,410,094 | 3,413,041 | RGD:6480464 | CTD | |
| G | RT1-CE7 | RT1 class I, locus CE7 |
|
multiple interactions | ISO | 20 | 3,410,094 | 3,413,041 | RGD:6480464 | CTD | |
| G | RT1-Da | RT1 class II, locus Da |
|
increases expression | ISO | 20 | 4,636,310 | 4,641,282 | RGD:6480464 | CTD | |
| G | RT1-M3-1 | RT1 class Ib, locus M3, gene 1 |
|
multiple interactions | ISO | 20 | 1,412,553 | 1,416,692 | RGD:6480464 | CTD | |
| G | RT1-M3-1 | RT1 class Ib, locus M3, gene 1 |
|
decreases expression | ISO | 20 | 1,412,553 | 1,416,692 | RGD:6480464 | CTD | |
| G | Ryr1 | ryanodine receptor 1 (skeletal) |
|
increases expression | ISO | 1 | 84,116,098 | 84,254,503 | RGD:6480464 | CTD | |
| G | Ryr1 | ryanodine receptor 1 (skeletal) |
|
increases expression | ISO | 1 | 84,116,098 | 84,254,503 | RGD:6480464 | CTD | |
| G | Ryr1 | ryanodine receptor 1 (skeletal) |
|
multiple interactions | ISO | 1 | 84,116,098 | 84,254,503 | RGD:6480464 | CTD | |
| G | Slc18b1 | solute carrier family 18, subfamily B, member 1 |
|
decreases expression | ISO | 1 | 22,201,424 | 22,255,955 | RGD:6480464 | CTD | |
| G | Slc25a36 | solute carrier family 25 (pyrimidine nucleotide carrier ), member 36 |
|
affects expression | EXP | 8 | 102,160,470 | 102,191,368 | RGD:6480464 | CTD | |
| G | Slc25a36 | solute carrier family 25 (pyrimidine nucleotide carrier ), member 36 |
|
increases expression | ISO | 8 | 102,160,470 | 102,191,368 | RGD:6480464 | CTD | |
| G | Smim11 | small integral membrane protein 11 |
|
increases expression | ISO | 11 | 32,294,155 | 32,303,989 | RGD:6480464 | CTD | |
| G | Smim3 | small integral membrane protein 3 |
|
decreases expression | ISO | 18 | 56,425,858 | 56,452,712 | RGD:6480464 | CTD | |
| G | Snrnp200 | small nuclear ribonucleoprotein 200 (U5) |
|
affects expression | ISO | 3 | 114,708,628 | 114,738,549 | RGD:6480464 | CTD | |
| G | Ssuh2 | ssu-2 homolog |
|
decreases expression | ISO | 4 | 148,211,602 | 148,229,983 | RGD:6480464 | CTD | |
| G | Tma16 | translation machinery associated 16 homolog (S. cerevisiae) |
|
decreases expression | ISO | 16 | 24,948,510 | 24,964,415 | RGD:6480464 | CTD | |
| G | Tmem254 | transmembrane protein 254 |
|
multiple interactions | ISO | 16 | 1,542,246 | 1,546,190 | RGD:6480464 | CTD | |
| G | Trub2 | TruB pseudouridine (psi) synthase homolog 2 (E. coli) |
|
affects expression | ISO | 3 | 8,769,049 | 8,774,733 | RGD:6480464 | CTD | |
| G | Xrcc3 | X-ray repair complementing defective repair in Chinese hamster cells 3 |
|
multiple interactions | ISO | 6 | 136,594,276 | 136,602,069 | RGD:6480464 | CTD | |
| G | Ybx3 | Y box binding protein 3 |
|
multiple interactions | ISO | 4 | 169,076,517 | 169,099,849 | RGD:6480464 | CTD | |
Term paths to the root
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




browse the term